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A B S T R A C T
Background
Indications for the use of negative pressure wound therapy (NPWT) are broadening with a range of systems now available on the
market, including those designed for use on clean, closed incisions and skin grafts. Reviews have concluded that the evidence for the
effectiveness of NPWT remains uncertain, however, it is a rapidly evolving therapy. Consequently, an updated systematic review of the
evidence for the effects of NPWT on postoperative wounds expected to heal by primary intention is required.
Objectives
To assess the effects of NPWT on surgical wounds (primary closure, skin grafting or flap closure) that are expected to heal by primary
intention.
Search methods
We searched the following electronic databases to identify reports of relevant randomised clinical trials: the Cochrane Wounds Group
Specialised Register (searched 28 January 2014); the Cochrane Central Register of Controlled Trials (CENTRAL; 2013, issue 12);
Database of Abstracts of Reviews of Effects (2013, issue 12); Ovid MEDLINE (2011 to January 2014); Ovid MEDLINE (In-Process
& Other Non-Indexed Citations 24 January 2014); Ovid EMBASE (2011 to January 2014 Week 44); and EBSCO CINAHL (2011
to January 2014). We conducted a separate search to identify economic evaluations.
Selection criteria
We included trials if they allocated patients to treatment randomly and compared NPWT with any other type of wound dressing, or
compared one type of NPWT with a different type of NPWT.
Data collection and analysis
We assessed trials for their appropriateness for inclusion and for their quality. This was done by three review authors working indepen-
dently, using pre-determined inclusion and quality criteria.
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Main results
In this first update, we included an additional four trials, taking the total number of trials included to nine (785 participants). Three
trials involved skin grafts, four included orthopaedic patients and two included general surgery and trauma surgery patients; all the
included trials had unclear or high risk of bias for one or more of the quality indicators we assessed. Seven trials compared NPWT with
a standard dressing (two of these were ’home-made’ NPWT devices), one trial compared one ’home-made’ NPWTwith a commercially
available device. In trials where the individual was the unit of randomisation, there were no differences in the incidence of surgical site
infections (SSI); wound dehiscence, re-operation (in incisional wounds); seroma/haematoma; or failed skin grafts. Lower re-operation
rates were observed among skin graft patients in the ’home-made’ NPWT group (7/65; 10.8%) compared to the standard dressing
group (17/66; 25.8%) (risk ratio (RR) 0.42; 95% CI 0.19 to 0.92). The mean cost to supply equipment for VAC® therapy was USD
96.51/day compared to USD 4.22/day for one of the ’home-made’ devices (P value 0.01); labour costs for dressing changes were similar
for both treatments. Pain intensity score was also reported to be lower in the ’home-made’ group when compared with the VAC®
group (P value 0.02). One of the trials in orthopaedic patients was stopped early because of a high incidence of fracture blisters in the
NPWT group (15/24; 62.5%) compared with the standard dressing group (3/36; 8.3%) (RR 7.50; 95% CI 2.43 to 23.14).
Authors’ conclusions
Evidence for the effects of negative pressure wound therapy (NPWT) for reducing SSI and wound dehiscence remains unclear, as does
the effect of NPWT on time to complete healing. Rates of graft loss may be lower when NPWT is used, but hospital-designed and
built products are as effective in this area as commercial applications. There are clear cost benefits when non-commercial systems are
used to create the negative pressure required for wound therapy, with no evidence of a negative effect on clinical outcome. In one study,
pain levels were also rated lower when a ’home-made’ system was compared with a commercial counterpart. The high incidence of
blisters occurring when NPWT is used following orthopaedic surgery suggests that the therapy should be limited until safety in this
population is established. Given the cost and widespread use of NPWT, there is an urgent need for suitably powered, high-quality trials
to evaluate the effects of the newer NPWT products that are designed for use on clean, closed surgical incisions. Such trials should
focus initially on wounds that may be difficult to heal, such as sternal wounds or incisions on obese patients.
P L A I N L A N G U A G E S U M M A R Y
Negative pressure wound therapy for acute surgical wounds
Negative pressure wound therapy (NPWT) is the application of suction (negative pressure) to wounds that are healing. NPWT has
been used for many years for the treatment of chronic wounds, such as leg ulcers and bed sores. More recently, the system has been
modified for use on clean surgical wounds, including skin grafts. We undertook a review of studies that compared NPWT with other
wound treatments in order to see whether NPWT really works. We found nine trials to consider. These showed that it is still not clear
whether NPWT promotes faster healing and reduces complications associated with clean surgery or skin grafts, or not.
B A C K G R O U N D
Description of the condition
It is estimated that between 187 and 281 million operations are
carried out annually worldwide, equating to one operation each
year for every 25 people (WHO 2009). This figure is higher in
high-income countries. For example, in Australia in 2008/09 it
can be calculated from hospital statistics that there was one elective
surgical procedure for every 12.4 people (Australian Institute of
Health and Welfare 2010).
Surgical wounds generally heal by primary intention during which
the wound edges are brought together so that they are adjacent to
each other - except in the case of skin grafts, where a larger surface
area is required to allow for contraction. Wound closure is usually
assisted by the use of sutures (stitches), staples, adhesive tape or
glue (Coulthard 2010), and healing begins within hours of closure
(Rodero 2010). However, some types of surgical wounds, such as
skin grafts and sternal wounds (Culliford 2007; Schimmer 2008),
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are more difficult to heal due to their anatomical position or an
increased likelihood of infection. So too are surgical wounds in
certain types of patients, such as the morbidly obese (Waisbren
2010).
Failure of a wound to heal may be due to underlying patient
characteristics such as age or medical conditions, including mal-
nutrition, obesity, uncontrolled diabetes, cardiovascular disease,
compromised immunity or infection (Baronski 2008). It may also
be the result of dehiscence (separation of the wound edges) or
separation of the of the graft from the wound bed. Reasons for
dehiscence are either technical, such as sutures breaking, cutting
through tissue or knots slipping, or inadequate splinting (Baronski
2008), or related to patient factors, such as those listed above and
particularly wound infection (Ortega 2010). Chronic obstructive
pulmonary disease is a major risk factor for dehiscence in sternal
surgery (Olbrecht 2006). The most serious complication of de-
hiscence is wound evisceration, where the wound separates com-
pletely, exposing the underlying organs (Harvey 2005).
Description of the intervention
Negative pressure wound therapy (NPWT) has been used to
treat wounds since the late 1990s (Fleischmann 1997; Morykwas
1997). NPWT is recommended for a diverse range of lesions in-
cluding open abdominal wounds (Stevens 2009), open fractures
(Stannard 2009), skin graft donor sites (Chio 2010), acute burns
(Molnar 2005), pressure ulcers (Mandal 2007), post-traumatic
wounds (Kanakaris 2007), diabetic foot ulcers (Eneroth 2008),
split-thickness skin grafts (Blume 2010), sternal wounds (Sjogren
2011), and, more recently, after clean surgery in obese patients
(Dragu 2011). NPWT is used prophylactically following skin
grafts and clean surgery to prevent a surgical site complication, in
contrast to its more frequent use in wounds healing by secondary
intention (left open to heal from the bottom up) such as chronic
or infected wounds.
NPWT consists of a closed, sealed system that applies negative
pressure (suction) to the wound surface. The wound is covered
or packed with an open-cell foam or gauze dressing and sealed
with an occlusive drape. Intermittent or continuous suction is
maintained by connecting suction tubes from the wound dressing
to a vacuum pump and liquid waste collector. Standard negative
pressure rates range from - 50 mmHg to -125 mmHg (Ubbink
2008; Vikatmaa 2008). The longest established device is the vac-
uum-assisted closure ((VAC® KCI, San Antonio, Texas) system
(Morykwas 1997), however alternatives have been developed and
are being used (Llanos 2006; Mody 2008; Rozen 2008). More
recently, portable versions of the device have been introduced and
are being used increasingly in community settings (Hurd 2014;
Ousey 2014). An emerging advance has been the addition of
’intillations’ of sterile water, saline or antibiotics to VAC therapy.
For example the new a new NPWTi system (V.A.C. VeraFlo™
Therapy, KCI USA, Inc., San Antonio, TX) delivers controlled
volumes of solution to aid wound healing (Gabriel 2014).
How the intervention might work
In humans, the wound healing process is regarded as occurring in
three consecutive and overlapping stages, namely: inflammation,
new tissue formation and remodelling (Gurtner 2008). The pre-
cise way in which NPWTmay aid this process is not clear. Experi-
mental evidence suggests thatNPWTmay assist wound healing by
increasing local blood flow and production of granulation tissue
(Xia 2014), and reducing bacterial contamination, oedema and
exudate. There may be other changes to the microenvironment of
the wound (Banwell 2003). One of the basic theoretical princi-
ples underpinning the development of NPWT is that it increases
perfusion or blood flow, but this has been challenged recently, as
in an experimental study that used healthy volunteers, local blood
flow decreased as suction pressure increased (Kairinos 2009).
Why it is important to do this review
Wounds that fail to heal may cause considerable distress to pa-
tients and impact negatively on the physical, social, emotional and
economic aspects of their lives (Andersson 2010). Investigations
into interventions to avoid wound breakdown are therefore im-
portant. NPWT was approved by the American Food and Drug
Administration (FDA) for the treatment of non-healingwounds in
1995 (Kloth 2002). More recently, a multi-national expert work-
ing group has issued guidelines for the use of the therapy for di-
abetic foot ulcers, complex leg ulcers, pressure ulcers, dehisced
sternal wounds, open abdominal wounds and traumatic wounds
(Expert Working Group 2008). While NPWT has become an ac-
cepted part of modern wound healing techniques, there have also
been reports of severe adverse events associated with the therapy.
Problems have included stomal dehiscence (Steenvoorde 2009),
extraperitoneal bladder leakage (Heuser 2005), necrotising fasciitis
(Citak 2010), bleeding after cardiac surgery (Petzina 2010), pain
(Apostoli 2008), secondary wound formation (Karabacak 2014),
and anxiety (Keskin 2008). Communiqués issued in 2009 by the
FDA reported six deaths and 77 injury reports associated with
the use of NPWT. The information sheets contained warnings
and recommendations for consumers and healthcare practitioners
about use of the treatment in certain circumstances (FDA 2009a;
FDA 2009b).
Although several reviews of NPWThave been published, none has
focused specifically on postoperative wounds expected to heal by
primary intention (Gregor 2008; Ubbink 2008; Vikatmaa 2008);
nor have any included an economic analysis. In addition, although
publication bias has been noted, both in terms of the majority of
trials being funded by manufacturers (Kairinos 2014; Vikatmaa
2008), and premature termination of studies (Gregor 2008), no
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sub-analyses to control for these potential biases have been con-
ducted. Recent reviews have concluded that the evidence for the ef-
fectiveness of NPWT remains uncertain, however, this is an evolv-
ing therapy and the indications for its use are widening. Conse-
quently, an updated systematic review to summarize evidence on
the effects of NPWT on the healing of surgical wounds healing
by primary intention is required.
O B J E C T I V E S
To assess the effects of NPWT on surgical wounds (primary clo-
sure, skin grafts or flap closure) that are expected to heal by pri-
mary intention.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included only randomised controlled trials (RCTs) that eval-
uated the effects of NPWT on the healing of surgical wounds.
Surgical wounds included split-skin grafts, full-skin grafts, flap
closure or any other primary wound closure. This criterion en-
compassed comparative full and partial economic evaluations con-
ducted within the framework of eligible RCTs (i.e. cost-effective-
ness analyses, cost-utility analyses, cost-benefit analyses and cost-
analyses). We did not include trials of skin graft donor sites or
wounds that were unable to be closed immediately because of dam-
aged tissue (for example in severe trauma), infection or chronicity.
Cross-over trials and quasi-randomised studies, where, for exam-
ple, treatment allocation was made through alternation or by date
of birth, were also ineligible.
Types of participants
We included trials involving people of any age, and in any care
setting, involving the use of NPWT for surgical wounds healing
by primary intention.
Types of interventions
The primary intervention was NPWT delivered by any mode
(for example vacuum-assisted closure (VAC® KCI, San Antonio,
Texas) or simple closed-system suction drainage), continuously or
intermittently over any time period. The comparison interven-
tions were any standard dressing (for example gauze) or any ad-
vanced dressing (for example hydrogels, alginates, hydrocolloids);
or comparisons between different negative pressure devices.
Types of outcome measures
Primary outcomes
• Mortality
• Adverse events (surgical site infection and dehiscence)
Secondary outcomes
• Time to complete healing
• Re-operation
• Seroma/haematoma
• Graft failure
• Fracture blisters
• Pain (measured by any valid pain assessment instrument)
• Quality of life (measured by any valid assessment
instrument)
• Cost (including: utility scores representing health-related
quality of life; treatment costs per patient per wound; costs of
health practitioner time or visits; costs of hospital stay for wound
healing; procedure costs to treat adverse events, infections or
complications; costs of hospital stay resulting from adverse
events and complications; incremental cost per life year gained;
incremental cost per quality adjusted life year and cost-benefit
ratio
Search methods for identification of studies
Electronic searches
For an outline of the search methods used in the first publication
of this review see Appendix 1.
For this first update we searched the following electronic databases
to identify reports of relevant randomised clinical trials:
• the Cochrane Wounds Group Specialised Register (searched
28 January 2014);
• the Cochrane Central Register of Controlled Trials
(CENTRAL 2013, Issue 12);
• Database of Abstracts of Reviews of Effects (2013, Issue 12);
• Ovid MEDLINE (2011 to January Week 3 2014);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations January 24, 2014);
• Ovid EMBASE (2011 to 2014 January 24);
• EBSCO CINAHL (2011 to 28 January 2014).
We used the following search strategy in the Cochrane Central
Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor Negative-Pressure Wound Therapy explode
all trees
#2 MeSH descriptor Suction explode all trees
#3 MeSH descriptor Vacuum explode all trees
4Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
#4 (“negative pressure” or negative-pressure or TNP):ti,ab,kw
#5 (sub-atmospheric or subatmospheric):ti,ab,kw
#6 ((seal* NEXT surface*) or (seal* NEXT aspirat*)):ti,ab,kw
#7 (wound NEAR/3 suction*):ti,ab,kw
#8 (wound NEAR/3 drainage):ti,ab,kw
#9 ((foam NEXT suction) or (suction NEXT dressing*)):ti,ab,kw
#10 ((vacuum NEXT therapy) or (vacuum NEXT dressing*) or
(vacuum NEXT seal*) or (vacuum NEXT assist*) or (vacuum
NEAR closure) or (vacuum NEXT compression) or (vacuum
NEXT pack*) or (vacuum NEXT drainage) or VAC):ti,ab,kw
#11 (“vacuum assisted closure technique” or VAC):ti,ab,kw
#12 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR
#9 OR #10 OR #11)
#13 MeSH descriptor Surgical Wound Infection explode all trees
#14 MeSH descriptor Surgical Wound Dehiscence explode all
trees
#15 surg* NEAR/5 infect*:ti,ab,kw
#16 surg* NEAR/5 wound*:ti,ab,kw
#17 surg* NEAR/5 site*:ti,ab,kw
#18 surg* NEAR/5 incision*:ti,ab,kw
#19 surg* NEAR/5 dehisc*:ti,ab,kw
#20 wound* NEAR/5 dehisc*:ti,ab,kw
#21 (#13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19
OR #20)
#22 (#12 AND #21)
The search strategies for Ovid MEDLINE, Ovid EMBASE and
EBSCO CINAHL can be found in Appendix 2; Appendix 3
and Appendix 4 respectively. We combined the Ovid MEDLINE
search with the Cochrane Highly Sensitive Search Strategy for
identifying randomised trials in MEDLINE: sensitivity- and pre-
cision-maximising version (2008 revision) (Lefebvre 2011). We
combined the EMBASE and CINAHL searches with the trial fil-
ters developed by the Scottish Intercollegiate Guidelines Network
(SIGN 2011).
We conducted separate searches to identify economic evaluations
in the following electronic databases:
• NHS Economic Evaluation Database (2013, Issue 12);
• Ovid MEDLINE (2011 to January Week 3 2014);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations 22 January 2014);
• Ovid EMBASE (2011 to 24 January 2014);
• EBSCO CINAHL (2011 to 28 January 2014)
We used economics filters developed by Centre for Reviews and
Dissemination in combination with terms to describe the con-
dition and intervention in Ovid MEDLINE, Ovid EMBASE
and EBSCO CINAHL searches (CRD 2010; see Appendix 5;
Appendix 6 and Appendix 7 respectively). We did not restrict any
of the above searches with respect to language, date of publication
or study setting.
We searched the following clinical trials registries for details of
relevant protocols and contacted the relevant research teams:
• Clinical trials.gov (http://www.clinicaltrials.gov/);
• World Health Organization (WHO) International Clinical
Trials Registry Platform (www.who.int/trialsearch);
• Australian and New Zealand Clinical Trials Registry (
www.anzctr.org.au);
• Current Controlled Trials.
Searching other resources
We checked the citation lists of papers identified by the above
strategies for further reports of eligible studies. We contacted cor-
responding authors of identified studies. In the first version of this
review we contacted the manufacturers and distributors of devices
used to deliver NPWT, such as Vacuum-Assisted Closure (VAC®
KCI, San Antonio, Texas); SNaP® Wound Care SystemDressing,
Spiracur Inc; Venrturi™ Avanti and Venturi™ Compact (Talley
Group, England); RENASYS EZ*; and Smith &Nephew.We did
not contact manufacturers or distributors for this update.
Data collection and analysis
Selection of studies
JW,WC andMS independently reviewed titles and abstracts iden-
tified through the search process. We retrieved full reports of all
potentially relevant trials for further assessment of eligibility based
on the inclusion criteria. Differences of opinion were settled by
consensus. There was no blinding of study authorship.
Data extraction and management
JW and MS independently extracted the following data using a
pre-designed checklist:
• methods (number of participants eligible and randomised,
adequacy of randomisation, allocation concealment, blinding,
completeness of follow-up);
• participant characteristics and exclusions;
• type of surgery;
• setting;
• study dates;
• interventions;
• number of participants per group;
• information about ethics approval, consent and conflict of
interest; and
• outcomes.
We resolved discrepancies through discussion. One review author
(JW) entered data into the Review Manager software (RevMan
2011), andMS checked data for accuracy. If information regarding
any data was unclear, we attempted to contact study authors of
the original reports to ask them to provide further details.
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Assessment of risk of bias in included studies
Two review authors independently assessed the eligible trials (JW
and MS) using the Cochrane Collaboration tool for assessing risk
of bias (Higgins 2011). This tool addresses six specific domains,
namely sequence generation, allocation concealment, blinding, in-
complete outcome data, selective outcome reporting and other is-
sues which may potentially bias the study (see Appendix 8 for de-
tails of the criteria onwhich the judgementwas based).We assessed
blinding and completeness of outcome data for each outcome sep-
arately. We completed a ’Risk of bias’ table for each eligible study.
We resolved disagreements between review authors by consensus.
We contacted investigators of included trials to resolve any ambi-
guities. We were to have reported bias, and more generally study
limitations within economic evaluations, using the checklist from
the NICE Guidelines Manual (NICE 2009). We have presented
assessment of risk of bias using a ’Risk of bias’ summary figure,
which shows all the judgements in a cross-tabulation of study by
entry.
Measures of treatment effect
For individual trials, we extracted the numbers with an event for
each treatment group andused them to calculate the risk ratio (RR)
with its 95% confidence interval (CI). For statistically significant
effects, we planned to calculate the number needed to treat for
an additional beneficial outcome (NNTB) or number needed to
treat for an additional harmful outcome (NNTH) from the risk
difference. Hoever, based on the quality of the data, we decided
not to conducted these calculations. For continuous outcomes, we
extracted the mean and standard deviation (SD) and calculated
the mean difference (MD) or, if the scale of measurement differed
across trials, the standardised mean difference (SMD), each with
its 95% CI.
Economic analyses
We were to have undertaken the following economic analysis but
no studies provided suitable data. However the methods remain
detailed here in the event that future updates of this review identify
economic data.
We will present a tabled analysis of the identified economic data in
accordance with current guidance on the use of economics meth-
ods in the preparation of Cochrane Reviews (Shemilt 2011). We
will classify economic evaluation according to the framework de-
scribed by Drummond and colleagues (Drummond 2005). We
will tabulate the main characteristics and results of the identified
economic evaluation studies and augment these with a narrative
description. This will discuss the methods used and compare the
key results of those studies.
The results of cost-effectiveness studies are likely to vary accord-
ing to the particular circumstances of each study. For example,
the comparator treatment, such as standard care, may differ for
different types of wounds and in different settings. Our analysis
will place the results of the economic studies in context and will
entail a discussion of scenarios that are likely to lead to the most
cost-effective use of the therapy, as well as the least cost-effective
use.
Costs
All substantial costs that are observed to differ between patients
administered NPWT and patients administered standard care are
intended to be captured and reported as part of the economic
analysis.
We will report unit costs along with the currency and price year in
each original study. These costs will then be converted to 2011 val-
ues by applying implicit price deflators for gross domestic product
(GDP) of that currency and then converted into the currencymost
frequently observed in the articles reviewed using GDP Purchas-
ing Power Parities (Shemilt 2010). This will allow readers of the
review to make meaningful comparisons between costs in studies
that may have been conducted in different countries and at dif-
ferent times.
The main costs are likely to be those associated with the NPWT
itself, specialist and other practitioner costs as measured by time
or number of visits, potential cost-savings from a change in the
number of bed days in hospital, and costs stemming fromdiffering
rates of adverse events and complications (including procedures
initiated due to the failure of wounds to heal, such as amputation).
The key cost drivers will be identified from the studies included.
This will enable users of the review to gain a clear understanding
of the nature of resource use associated with NPWT.
Outcomes
The primary trial outcome (adverse events) and secondary out-
come (time to complete healing) are relevant to the economic anal-
ysis as they may indicate a difference in the number of hospital
bed days and specialist time required and a possible improvement
in quality of life for the patient.
Wewill examine information on the change in health-related qual-
ity of life (HR-QoL) via utilities measured by a multi-attribute
utility instrument (MAUI) or other approaches (such as the time
trade-off, standard gamble) where possible. Ideally these data will
be reported in trials for both the group treated with NPWT and
a control group receiving the comparator wound care. The util-
ity data will need to be assessed for comparability and representa-
tiveness considering issues such as the types of wounds included,
the patient populations, timing of the baseline point and follow-
up collection, the MAUI used and the algorithm for scoring the
MAUI. We will present discussion of the potential impact on HR-
QoL attributable to the intervention as part of the analysis.
If differences can be observed in the rates of adverse events, wound
infections and complications resulting from the treatment of the
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wound, we will discuss the economic implications as part of the
economic analysis.
Unit of analysis issues
It is possible that wounds rather than participants may be ran-
domised. Where there is evidence that multiple wounds on a sin-
gle person have been analysed incorrectly (that is, by considering
outcomes for multiple wounds or grafts as independent), we will
seek further information from the trialist. Cross-over trials were
excluded and cluster-randomised trials were not expected for this
type of intervention.
Dealing with missing data
Where possible, we will perform all analyses using the intention-
to-treat (ITT) principle, that is, participants will be analysed ac-
cording to their allocated treatment group. Where it appears that
data have been excluded from the analyses, we will contact au-
thors for these missing data. If data remain missing, despite our
best efforts to obtain them, we planned an available-case analysis,
based on the numbers of patients for whom outcome data were
known. We also planned best-case and worst-case analyses. In the
event of missing standard deviations (SD) we planned imputation
from other studies or, where possible, calculation from standard
errors (SE) using the formula SD = SE x
√
N , where these were
available (Higgins 2011).
Assessment of heterogeneity
We assessed heterogeneity visually and by using the Chi2 test with
significance being set at P less than 0.10. In addition, we inves-
tigated the degree of heterogeneity by calculating the I2 statistic
(Higgins 2011). We planned to explore potential causes of mod-
erate to significant heterogeneity (I2 > 30%) and use a random-
effects approach to the analysis, but this was not necessary.
Assessment of reporting biases
If sufficient studies had been identified (more than 10) we had
planned to assess reporting bias using funnel plots (Higgins 2011).
Data synthesis
Where studies were clinically similar and outcome measurements
comparable, we pooled results using a fixed-effect model and re-
ported the pooled estimate together with its 95% CI. We con-
ducted a narrative review of eligible studies where statistical syn-
thesis of data from more than one study was not possible or con-
sidered inappropriate, for example if the I2 statistic was above
60%. There were no time-to-event data so estimates of hazard ra-
tios (HR) and 95% confidence intervals (CI) were not required
(Altman 2001).
Subgroup analysis and investigation of heterogeneity
Weplanned to analyse potential sources of heterogeneity using the
following subgroup analyses:
• type of setting (community, hospital, inpatient, outpatient);
• type of negative pressure device (such as vacuum-assisted
closure (VAC® KCI, San Antonio, Texas), RENASYS systemT M
(Smith & Nephew, UK), Chariker-Jeter gauze-based negative
pressure systems (V1STA, Versatile-1 and EZ-Care; Smith &
Nephew Inc) and non-commercial systems;
• type of surgery (traumatic wounds, reconstructive
procedures, other post-surgical wounds; skin grafts);
• type of comparison dressing (saline gauze, Jelonet,
hydrocolloid, foam, alginate); and
• intermittent versus continuous negative pressure.
Sensitivity analysis
We planned to perform sensitivity analyses to explore the effect of
the following criteria:
• concealment of allocation (allocation adequately concealed
versus not reported or inadequate);
• duration of follow-up (no stated follow-up versus any
follow-up; follow-up for less than four weeks versus follow-up of
four weeks or longer); and
• type of randomisation (truly randomised with adequate
method of generating the randomisation sequence versus not
reported).
R E S U L T S
Description of studies
See Characteristics of included studies; Characteristics of excluded
studies and Characteristics of ongoing studies.
Results of the search
Interventions search
For this first update, we identified 177 new, unique records
through our electronic search. After reading the titles and ab-
stracts,166 were excluded as irrelevant.We retrieved the remaining
11 full-text papers for inspection. From these we selected an addi-
tional four papers, with results from four trials, for inclusion in the
review (Crist 2014; Masden 2012; Petkar 2012; Stannard 2012),
bringing the total number of included studies to nine. Additional
information was sought from the correspondence author of each
of the trials. Responses, with additional, useful information were
received from the authors of Crist 2014 and Stannard 2012.
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In the first version of this review a search of trial registry platforms
identified 17 protocols related to NPWT. Eleven of these planned
to investigate chronic wounds and were ineligible. Of the six re-
maining trials, five named investigators and one named a com-
pany (KCI) as the investigator. We attempted contact with the five
study authors, three of whom did not respond. The investigator
of one of the remaining protocols stated that the planned start
date for the trial was in early 2011 (Chan 2011). For this update
we have been unable to find any further information about this
trial. We were also unable to contact the other author (Graves
2011). To our knowledge, neither trial has been published. With
regard to the company trial, KCI advised us that the trial will not
be conducted. No participants were enrolled in the study, all sites
were closed and all site payments reconciled. No reason was pro-
vided for terminating the study. In the first version of the review,
we sent emails to all the manufacturers mentioned in our search
strategy. We were advised of one animal study, but identified no
further human trials meeting our inclusion criteria; we did not
contact manufacturers for this update. Our updated search of trial
registries identified 20 protocols that potentially meet our criteria.
Nine of these were actively recruiting, and five of these named a
manufacturer as either a sponsor or collaborator.
Two trials appear to be on-going and are classified as Studies
awaiting classification (Chan 2011; Graves 2011).
Economic analysis search
Electronic searches yielded 115 references in the first version of our
review, none of which met our economic inclusion criteria. For
this update, a further 77 trials were identified. One of these trials
appeared relevant, but it was an abstract from conference presen-
tation and we were unable to extract sufficient information from
the abstract for this review (see Mullins 2012 in Studies awaiting
classification). Attempts to contact the author were unsuccessful.
We will wait for a paper to be published.
Included studies
Types of participants
In the initial review, the five included trials enrolled a total of 280
participants (Chio 2010; Dorafshar 2011; Howell 2011; Llanos
2006; Pachowsky 2011). A further 516 participants from four tri-
als have been added in this update (Crist 2014; Masden 2012;
Petkar 2012; Stannard 2012). Participants in three trials under-
went skin grafts: Chio 2010 investigated the forearm donor site in
54 participants undergoing a radial forearm free flap; Llanos 2006
enrolled 60 burns patients who had split-thickness skin grafts ap-
plied to their burn site; and Petkar 2012 recruited 71 patients
deemed fit for split-skin grafting. In the other trials, Dorafshar
2011 recruited 87 patients with acute wounds resulting from
trauma, surgery or dehiscence; Howell 2011 included 60 patients
undergoing a total knee arthroplasty who were obese and at risk of
infection; Pachowsky 2011 enrolled 19 patients with closed sur-
gical wounds after total hip arthroplasty; 115 participants in the
Crist 2014 and 249 participants in the Stannard 2012 trials were
also orthopaedic patients; and in theMasden 2012 trial, the target
group was patients requiring primary closure for lower extremity
or abdominal wounds, with 81 of the 93 patients randomised be-
ing available for analysis. Six trials were conducted in the USA
(Chio 2010; Crist 2014; Dorafshar 2011; Howell 2011; Masden
2012; Stannard 2012), one in Chile (Llanos 2006), one in Ger-
many (Pachowsky 2011), and one in India (Petkar 2012).
Types of interventions
Four trials compared the VAC® (KCI, San Antonio, Texas) neg-
ative pressure device vacuum-assisted closure, set to -125 mmHg
with a standard dressing (Chio 2010;Howell 2011;Masden 2012;
Stannard 2012). The comparison standard dressings varied be-
tween the trials: Chio 2010 used sterile surgical foam, cut to size
and wrapped in Adaptic dressing; Howell 2011 used a sterile gauze
dressing secured with a perforated, stretchable cloth tape; Masden
2012 described the control dressing as a non-adhesive silicone layer
(Mepitel; Mölnlyncke Health Care AB, Göteborg, Sweden) and a
bacteriostatic single silver layer (Acticoat, Smith &Nephew, Hull,
United Kingdom); whereas the Stannard 2012 trial described the
dry dressing simply as a ’standard gauze dressing’.
Crist 2014 used VAC® (KCI, San Antonio, Texas) as the inter-
vention device and compared this to a standard gauze dressing.
Pachowsky 2011 used the PREVENA T M system (KCI, San Anto-
nio, Texas) for the intervention treatment and a dry wound dress-
ing as the control treatment. Three trials developed non-standard
negative pressure devices: Llanos 2006 used the hospital’s central
aspiration system at a pressure of -80 mmHg to achieve a vacuum,
the comparison dressing was identical in both groups, but no pres-
sure was applied to the aspiration tubing in the control group;
Petkar 2012 also used the hospital’s continuous wall suction sys-
tem at -80 mmHg to create the ’vacuum’ for the negative pressure
dressing intervention, using Vaseline gauze and conventional cot-
ton gauze and elastic bandages over the graft in the control group;
Dorafshar 2011 compared two negative pressure systems: VAC®
KCI (San Antonio, Texas) and a subatmospheric pressure wound
therapy system (GSUC), which is a locally developed system based
on a gauze dressing moistened with 0.9% normal saline and sealed
with an occlusive cover, a red rubber catheter is placed in the mid-
dle of the dressing and attached to continuous wall suction at -75
mmHg to -80 mmHg.
Types of outcomes
Four treatment comparisons are included in the review. For the
first, ’negative pressure closure versus standard dressing’, incidence
of adverse events was the only pre-specified primary outcome re-
ported (Crist 2014; Howell 2011;Masden 2012; Stannard 2012),
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with no trials reporting on mortality. Adverse events included
surgical site infection (Crist 2014; Howell 2011; Masden 2012;
Stannard 2012), and dehiscence (Masden 2012; Stannard 2012).
Secondary outcomes for this comparison included time to com-
plete healing (Howell 2011), reoperation (Llanos 2006; Masden
2012; Petkar 2012), seroma/haematoma (Pachowsky 2011), graft
failure (Chio 2010), and fracture blisters (Howell 2011). In the
Chio 2010 trial outcomes were measured two weeks after surgery;
in the Crist 2014 and Howell 2011 trials participants were fol-
lowed up for 12 months; Dorafshar 2011 assessed outcomes on
day seven; and Llanos 2006 assessed outcomes when wounds were
uncovered at four days post-surgery. The average follow-up period
was 113 days in the Masden 2012 trial; Pachowsky 2011 con-
ducted ultrasound examinations on days five and 10 post surgery;
and Petkar 2012 followed participants for one month. The follow-
up period was unclear in the Stannard 2012 trial.
Only one trial was included in the second treatment comparison
of ’one negative pressure closure versus another negative pressure
closure’. Dorafshar 2011 compared theGSUC systemwithVAC®
(KCI, San Antonio, Texas). The trial reported on outcomes of
interest to this review including adverse events, pain and cost.
Two trials investigated the third treatment comparison of ’non-
commercial NPWT versus standard care’, but reported only
on secondary outcomes in the review, specifically: re-operation
(Llanos 2006; Petkar 2012), graft loss (Llanos 2006), length of
stay (Llanos 2006), and cost (Petkar 2012).
We included a fourth comparison, ’commercially funded ver-
sus non-commercially funded trials’, which included all of the
above outcomes (Chio 2010; Crist 2014; Dorafshar 2011; Howell
2011; Llanos 2006;Masden 2012; Pachowsky 2011; Petkar 2012;
Stannard 2012).
Other outcomes, such as median graft loss, time from grafting to
hospital discharge and rates of change in surface area and wound
volume, were reported by trialists, but these datawere not included
in our pre-specified primary or secondary outcomes, so results have
not been included in this review.
Excluded studies
In the first version of this review five trials were excluded (Hu
2009; Johannesson 2008; Kim 2007; Moues 2004; Moues 2007).
The intervention dressing in one trial was not a negative pressure
device (Johannesson 2008); one was not a randomised controlled
trial (Kim 2007); and three did not include acute wounds (Hu
2009; Moues 2004; Moues 2007). Two trials previously classi-
fied as ’Studies awaiting classification’, have been re-classified as
’Excluded studies’ as no further information about these stud-
ies was available (Braakenburg 2006; Moisidis 2004). For the
current update we have excluded a further five studies: Albert
2012 (no acute wounds); Banasiewicz 2013 (included participants
with infected wounds); Bondoki 2011 (prospective cohort study);
Eisenhardt 2012 (none of our outcomes of interest were reported);
Grauhan 2013 (quasi randomised by time of operation).
Risk of bias in included studies
See Figure 1 and Figure 2 for the ’Risk of bias’ summary.
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Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
Allocation
Sequence generation
Seven of the nine investigators described some process used to
generate the random allocation list. A computer-based random-
number generator was used in five trials (Chio 2010; Crist 2014;
Llanos 2006; Petkar 2012; Stannard 2012), and a web-based ran-
dom-number generator in a sixth (Dorafshar 2011).Masden 2012
used a ’block randomization protocol’ but it was unclear whether
this was computer generated. The two other studies did not specify
how the sequence was generated (Howell 2011; Pachowsky 2011).
Allocation concealment
The method used for allocation concealment was unclear in the
Dorafshar 2011; Masden 2012; Pachowsky 2011 and Stannard
2012 trials. In the Dorafshar 2011 study, participants were allo-
cated to their group “by drawing a previously prepared card”, how-
ever, it was unclear whether cards were concealed until the point
of randomisation. Opaque sealed envelopes were used by Howell
2011 and Crist 2014. Allocation in the Chio 2010, Llanos 2006
and Petkar 2012 trials was not concealed, open lists were used so
the next allocation would have been predictable.
Blinding
Participants and personnel
The appearance of dressings was dissimilar in theChio 2010; Crist
2014; Dorafshar 2011; Howell 2011; Masden 2012; Pachowsky
2011; Petkar 2012 and Stannard 2012 trials, so blinding was im-
possible. Dressings were identical in the Llanos 2006 trial, and
both groups had tubing attached to a suction apparatus, however,
participants and staff would almost certainly have been aware if
suction was activated.
Outcome assessment
Two trials did not blind outcome measurement (Chio 2010;
Dorafshar 2011), and it was unclear in the Howell 2011; Petkar
2012, and Stannard 2012 trials whether outcome assessment had
been blinded. Ultrasound was used to assess outcomes in the
Pachowsky 2011 trial, but it was not stated whether the ultrasono-
grapher was blinded to allocation. In the Llanos 2006 study, as-
sessment was conducted via photographs and the person assessing
the photographs was “masked to which intervention the patient
had received”. Outcome assessors were also unaware of group al-
location in the Crist 2014 and Masden 2012 trials.
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Incomplete outcome data
All participants were included in the analyses of five trials
(Dorafshar 2011; Howell 2011; Llanos 2006; Pachowsky 2011;
Petkar 2012). In the Chio 2010 trial four (14.8%) participants in
the NPWT group were unavailable for follow-up, but complete
follow-up data were reported for the control group, therefore Chio
2010 was deemed to be at a high risk of attrition bias. Similarly,
in the Crist 2014 trial,10.9% of the participants in the NPWT
group and 30.0% of the control group were lost to follow-up, so
the trial was classified as being at high risk for this domain. In the
Stannard 2012 trial, a total of 249 patients were recruited from
four hospitals: results were reported for all of these participants at
hospital discharge and at long-term follow-up (follow-up period
not defined). Since four hospitals were involved in this study, it
seems unlikely that complete follow-up would have occurred for
all of those recruited, which suggests an ’available case’ analysis.
Consequently, we have classified this trial as being at uncertain
risk of bias. In the Masden 2012 trial, 12 participants were lost
to follow-up, but the numbers were equally distributed across the
groups, so we assigned the study a low risk status for attrition bias.
Selective reporting
In the Chio 2010; Crist 2014; Dorafshar 2011; Howell 2011;
Llanos 2006; Masden 2012; Pachowsky 2011; Petkar 2012 and
Stannard 2012 trials each of the pre-specified outcomes, as defined
in the methods section of the papers, was reported in the results.
No published protocol was available for six of the trials (Chio
2010;Howell 2011; Llanos 2006;Masden 2012; Pachowsky 2011;
Petkar 2012). In the Dorafshar 2011 trial, assessment measures
reflected the pre-defined outcomes listed in the published proto-
col (NCT00724750), however, the study began in 2006 but the
protocol was first published in July 2008, so there was potential for
study characteristics to have changed before or during the study.
Similarly, the Stannard 2012 trial was registered nine months af-
ter data collection ceased. Crist 2014 was the only investigator to
pre-register the trial and, while the protocol nominated one pri-
mary outcome (infection) and four secondary outcomes (wound
drainage, hospital length of stay, dressing supply costs and nursing
time costs), the study abstract reported only wound infection and
length of stay. The full paper has not yet been published.
Other potential sources of bias
A manufacturer funded the Howell 2011 trial, which also con-
tained unequal numbers in each arm of the trial. This trial was
stopped early due to an unacceptably higher rate of blisters among
patients in the negative pressure group. The Pachowsky 2011 trial
was also manufacturer-funded and one of the authors received
conference funding from the manufacturer of the trial interven-
tion. The Stannard 2012 trial was manufacturer-sponsored and
the trialist is also a consultant with KCI. Two investigators in the
Masden 2012 trial are consultants for KCI. Two of the authors in
the Crist 2014 trial have been consultants for KCI and have re-
ceived funding from the company for previous trials. The current
trial however was not company-sponsored (correspondence with
the author).
A co-intervention (a bacteriostatic single silver layer) was included
as part of the control group dressing in the Masden 2012 trial.
In the Stannard 2012 study, some participants had more than one
wound. Data were analysed by wounds, rather than by individu-
als, creating the possibility of a ’unit of analysis error’. We have
presented data from this study separately.
Effects of interventions
Comparison 1: Negative pressure wound therapy
compared with standard dressing (six trials, 189
participants)
Primary outcomes
Mortality
Although not directly reported, results indicate that no participant
died during any of the trials.
Adverse events
Surgical site infection
Four trials with a total of 498 participants and of variable quality
reported data for this outcome (Crist 2014; Howell 2011;Masden
2012; Stannard 2012). Data from three studies (232 participants)
could be combined in themeta-analyses (Crist 2014;Howell 2011;
Masden 2012). No differences in the rate of surgical site infection
(SSI) were noted; RR 1.02 (95% CI 0.41 to 2.54, Analysis 1.1).
Stannard 2012 analysed data by wound, not by individual, and we
have presented data from this study in a separate forest plot. Results
favoured the NPWT group (14/144; 9.7%) compared with the
standard dressing group (23/122; 18.9%) (RR 0.52, 95% CI 0.28
to 0.96, P value 0.04, Analysis 1.2).
Dehiscence
Two studies (203 participants) provided dehiscence rates (Masden
2012; Stannard 2012). In the Masden 2012 trial the analysis was
by individual and there were no between-group differences for
dehiscence outcome; RR 1.22 (95% CI 0.65 to 2.30, Analysis
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1.3). Stannard 2012 also assessed dehiscence, but outcomes were
analysed by wound, not by individual. In the NPWT group 12/
139 (8.6%) wounds dehisced compared with 20/122 (16.4%)
in the standard dressing group; RR 0.48(95% CI 0.22 to 1.03,
Analysis 1.4). This finding contained a ’unit of analysis’ issue,
which was not adjusted for, so results should be interpreted with
caution. In other words, if the ’clustering effect’ is not adjusted for
in the analysis, the standard error of the intervention effect may
be too small, which has implications for the statistical significance
of the comparison.
Secondary outcomes
Time to complete healing
In the Howell 2011 trial, there was no reported difference in time
towound closure between groups (negative pressure 4.3 days; static
pressure 4.1 days). None of the other five trials provided data for
this outcome (Chio 2010; Crist 2014; Masden 2012; Pachowsky
2011; Stannard 2012).
Re-operation
There are two sub-groups for this outcome, incisional wounds and
skin grafts. In theMasden 2012 trial (81participants), therewas no
difference between groups in the re-operation rates for incisional
wounds. Whereas in two trials of uncertain to high risk of bias that
assessed re-operation rates among skin graft patients, pooling of
data showed that NPWT was more effective than other dressings;
RR 0.42 (95% CI 0.19 to 0.92; 131 participants; Llanos 2006;
Petkar 2012). When data from these three trials were combined
there was a 40% reduction in the re-operation rates favouring the
NPWT group, but the true rate for the NPWT intervention lies
somewhere between a 66% reduction and a 5% increase in re-
operation rates; RR 0.60 (95% CI 0.34 to 1.05) (Analysis 1.5).
Seroma/haematoma
The Pachowsky 2011 trial, with only 19 post-arthroplasty partici-
pants, showed a lower seroma rate in the NPWT group compared
to the standard dressing group RR 0.49 (95%CI 0.23 to 1.05) but
confidence intervals were wide indicating that NPWT may lead
to a 51% reduction or to a 5% increase in seroma rates (Analysis
1.6).
Graft failure
Chio 2010 (50 participants) reported on graft failure: there were
no differences between the groups for failure rates at either two
weeks or one month post surgery (Analysis 1.7).
Fracture blisters
The Howell 2011 trial was stopped early due to a high rate of
fracture blisters in the NPWT group; RR 7.50 (95% CI 2.43 to
23.14; Analysis 1.8).
Length of hospital stay
There was no reported difference in the length of hospital stay
in the Stannard 2012 trial (mean NPWT 2.5 days and standard
dressing 3.0 days; P value 0.10)
Pain, quality of life, cost
None of the studies included in this comparisonprovidedmeasures
for the outcomes of pain, quality of life or cost (Chio 2010; Crist
2014; Howell 2011; Masden 2012; Pachowsky 2011; Stannard
2012).
Comparison 2: One negative pressure closure
method (GSUC) compared with another negative
pressure closure method (VAC® KCI, San Antonio,
Texas) (one trial, 87 participants)
Primary outcomes
Mortality
No deaths were reported in the trial.
Adverse events
No data were reported for adverse events.
Secondary outcomes
Seroma/haematoma
Dorafshar 2011 (87 participants) showed no difference in rates
of haematoma between groups (VAC® 1/42; GSUC 0/45); (RR,
0.31, 95% CI 0.01 to 7.44; Analysis 2.1).
Time to complete healing
The trial reported no data for time to complete healing.
Pain
Pain before, during and after dressing changes was reported to be
lower in the GSUC group than in the VAC® group (P value 0.02)
(Dorafshar 2011).
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Quality of life
Quality of life was not measured in this trial.
Cost
A within-trial cost analysis was undertaken by Dorafshar 2011,
who reported that the mean cost of supply equipment for VAC®
therapy was USD 96.51/day compared to USD 4.22/day for the
GSUC therapy (P value 0.01). The daily labour costs to change
the dressings were USD 21.18/day for GSUC versus USD 25.55/
day for VAC® (P value 0.11). Overall, the costs in the VAC®
groupweremore than four times asmuch as the costs in theGSUC
group.
Comparison 3: Non-commercial NPWT versus
standard care (two trials, 131 participants)
Primary outcomes
Mortality
Nodeaths were reported in either trial (Llanos 2006; Petkar 2012).
Adverse events
Noadverse eventswere reported in either trial (Llanos 2006; Petkar
2012).
Secondary outcomes
Re-operation
Both Llanos 2006 and Petkar 2012 used ’home-made’ devices to
create negative pressure over the wounds. When compared with
standard care, their products were more effective at preventing re-
operation; RR0.42 (95%CI 0.19 to 0.92; Analysis 3.1).However,
both trials were at uncertain or high risk of bias for important
domains, such as allocation concealment.
Graft loss
Llanos 2006 reported lower rates of graft loss in the NPWT group
compared to controls (median percent loss in NPWT 0.0%, range
0.0 to 62%; control group 12.8%, range 0 to 79.9%; P value
0.001). Petkar 2012 also reported higher rates of graft take by day
14 (NPWT 95.29%, SD 5.89; control 85.89%, SD 25.10).
Length of hospital stay
The median length of stay in the Llanos 2006 trial was reported
to be 13.5 days for the NPWT group compared with 17.0 days
for the control group (P value 0.01).
Time to complete healing
No data were reported for time to complete healing.
Pain
No data were reported for pain.
Quality of life
Quality of life was not measured in these trials.
Cost
Petkar 2012 reported that the cost of their home made vacuum-
closure assembly for an average size of wound was approximately
GBP 6.27.
Comparison 4: Commercially funded compared with
non-commercially funded (nine trials, 785
participants)
To assess the effect of manufacturer funding we combined all out-
comes from all trials (Analysis 4.1); three sub-groups were in-
cluded.
• ’Manufacturer-funded’ (four trials using commercial
NPWT devices, 426 participants). There was a positive effect
favouring commercial NPWT devices (RR 0.73, 95% CI 0.54 to
0.97; Howell 2011; Masden 2012; Pachowsky 2011; Stannard
2012).
• ’Non-manufacturer funded’ (two trials using commercial
NPWT devices, 141 participants). No differences between
groups were found in the non-commercially funded trials that
used a commercial NPWT device (Chio 2010; Crist 2014).
• ’Non-manufacturer funded, using non-commercial NPWT
devices’ (three trials, 218 participants). The non-commercial
NPWT devices were effective in reducing the number of adverse
outcomes (Dorafshar 2011; Llanos 2006; Petkar 2012); RR 0.68
(95% CI 0.52 to 0.87).
D I S C U S S I O N
Summary of main results
14Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wound complications
This systematic review examined the evidence from randomised
controlled trials (RCTs) that focused on the effects of negative
pressure wound therapy (NPWT) for acute surgical wounds. Four
new trials were added to this update bringing the total number of
trials to nine and total number of participants to 785. Although
NPWTiswidely used and is supported for use in a range of surgical
applications (Krug 2011), evidence to support or refute its effects
on outcomes for acute surgical wounds remains unclear.
Trials in this review included use of NPWT after orthopaedic
surgery, skin grafts and general surgery. We found evidence, from
three studies, which showed equivalent rates of wound infection
when NPWT was compared with standard dressings. Similarly,
NPWT had no effect on dehiscence rates.
Three trials suggested a benefit of NPWT for skin graft survival
(Chio 2010; Llanos 2006; Petkar 2012), and one trial suggested a
benefit in prevention of seroma or haematoma (Dorafshar 2011;
Pachowsky 2011), but all of these trials were at unclear or high
risk of bias, which reduces our confidence in the results. Con-
versely, there was evidence for increased harm cause by the use of
NPWT in one trial, when skin blisters formed around the edge
of the NPWT dressing (Howell 2011). In this trial, the dress-
ing-associated blister rate was 63% in the NPWT group (Howell
2011), which compares poorly with the rates of 2.4% to 26.0%
seen in other recent trials where modern wound dressings have
been used for postoperative orthopaedic wounds (Abuzakuk 2006;
Koval 2007; Ravenscroft 2006; Ravnskog 2011), and was the rea-
son for the early termination of the trial. It is unclear why skin
blisters occur after orthopaedic surgery, but this may be due to
postoperative swelling, which leads to sheer or friction when the
tape securing the dressing is stretched (Ravenscroft 2006).
It is also unclear which NPWT system should be used to deliver
the therapy. Although there is a substantial literature relating to
wound healing using the vacuum-assisted closure (VAC® KCI,
San Antonio, Texas) system (Morykwas 1997), our review failed
to support the use of a commercial device for acute wounds. These
systems are very expensive and our results suggest that alternative,
cheaper methods may be as effective. For example, we have shown
inAnalysis 4.1 that commercialNPWTreduced the overall wound
related complications by 27%, whereas hospital-devised and built
systems reduced the complication rate by 63%.
Cost
Combined equipment and labour costs were four times lower
when a hospital-devised and built system was used than when a
commercial system was used for delivering NPWT (USD 25.40/
day compared to USD 110.06/day). This was due entirely to
higher equipment cost for the commercial product, as the cost for
labour to change the dressings was similar (Dorafshar 2011). A
second non-commercial NPWT trial found that use of the home-
made vacuum-closure assembly added only around GBP 6.27 to
the standard care costs (Petkar 2012). Although these cost data
come fromonly two trials, additional studies are unlikely to change
this finding unless equipment costs from commercial manufac-
tures reduce substantially. Innovative attempts to develop hospi-
tal-based systems are increasing in order to find ways around these
costs (Mody 2008; Perez 2010; Rozen 2008; Shalom 2008).
Pain
Pain levels in one study were significantly lower during and af-
ter dressing changes in the hospital-based negative pressure group
(Dorafshar 2011). However, the hospital-based device used con-
tinuous suction at -75 mmHg to -80 mmHg, whereas the VAC®
system was set between -75 mmHg to -125 mmHg, which may
account for the reported difference.
Overall completeness and applicability of
evidence
Indications for the use of NPWT in closed surgery are broadening
(DeCarbo 2010; Pachowsky 2011), with a range of new systems
on the market, including those designed for use on closed clean
wounds (Allen 2011). However, the studies eligible for inclusion
in our review represented a relatively narrow focus; there were
three on patients with skin grafts, two trials included patients with
acute wounds from trauma or surgery and four recruited patients
undergoing a planned total knee or hip arthroplasty. Trials were
small, with the largest enrolling 249 patients; the average number
of subjects amongst the other trials was 65. Negative pressure lev-
els varied between trials and between device types, with hospital
aspiration systems generally using a lower pressure than the VAC®
system. Whether different pressures produce different outcomes
is unclear from our results, but animal studies indicate that per-
formance is similar across the range of pressures used in the trials
we included (Morykwas 2001). Another limitation was a variation
in the follow-up times, which ranged from the fourth postopera-
tive day (Llanos 2006) to 12 months post surgery (Howell 2011).
Finally, included trials were geographically limited; six were con-
ducted in North America, one in South America, one in India and
one in Germany, further restricting the external validity of results.
In light of these limitations, uncertainty remains about whether
NPWT should be used at all for closed surgical wounds, unless
there are reasons to believe that the wound may be difficult to
heal. There are also important questions about the use of NPWT
for orthopaedic surgery; one trial in this category was terminated
early because of high blister rates.
Quality of the evidence
Limitations in study design and implementation
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Risk of bias was assessed according to six domains: sequence gen-
eration; allocation concealment; blinding; selective outcome re-
porting, incomplete follow-up and other potential biases. Our as-
sessments of the risk of bias for a number of these domains in all
the included studies showed limitations in study design and im-
plementation, which have been reported elsewhere in the review
(Figure 1).We had particular concern that for studies where blind-
ing of the intervention is difficult or impossible, there was subse-
quent uncertainty about allocation concealment and blinding of
outcome assessment. Accordingly, the quality of the evidence was
considered to be unclear for all of the outcomes.
Indirectness of evidence
The review was limited by a lack of conformity; in both the exper-
imental and the control interventions. For example the negative
pressure devices used varied between studies, as did the control
dressings. Consequently, the evidence was restricted to indirect
comparisons between these varied interventions. Additionally, the
review aimed to assess NPWT for acute surgical wounds, but its
use was investigated in a limited range of types of surgery. As a
result, the evidence may be regarded as indirect for other types of
surgery. Finally, direct evidence of the effect of the intervention on
wound infection or dehiscence - arguably the most important ad-
verse outcomes of surgery - was reported in only two trials. Taken
together, these limitations restrict confident decision-making con-
cerning the use of NPWT for acute wounds.
Unexplained heterogeneity or inconsistency of results
Heterogeneity was 30% or less In all of the pooled outcomes, how-
ever, there was some expected heterogeneity between sub-groups,
due either to different types of surgery (acute wounds versus skin
grafts; Analysis 1.1) or differences in interventions (Analysis 4.1).
Imprecision of results
Confidence intervals (CIs) were wide in the pooled outcomes, but
few studies were included, so future trials may have an impact on
the certainty of these results. Two of the single study outcomes
showed evidence of effect. In the Stannard 2012 trial, there was
some uncertainty around the effect size with CIs between 0.28 and
0.96. A much higher level of uncertainty around the effect size
was apparent in the Howell 2011 trial, where NPWT was more
likely to cause fracture blisters than the standard dressing. The CIs
in this trial (2.43 to 23.14) indicated the high level of uncertainty
around the effect size. Further research is therefore very likely to
have an important impact on the confidence of the estimate of
effect for most of the outcomes measured in this review.
Publication bias
We feel confident that our comprehensive electronic searches iden-
tified all existing, published randomised controlled trials address-
ing the review question, helping to limit bias in the review pro-
cess. However, most of the trials identified through a search of
the Clinical Trial Registries have not been published and we were
unable to track down any information about them. Moreover, the
scant contribution of the nine included trials, in the face of such
wide use of NPWT, is unusual. These two factors may or may not
indicate publication bias.
Potential biases in the review process
Clearly described procedures were followed to prevent potential
bias in the review process. A careful literature searchwas conducted
and the methods we used were transparent and reproducible. It
is possible that trials published in journals that were outside our
search strategy may have been missed. None of the authors of the
review has any conflicts of interest or associations with manufac-
turers of products included in this review.
Agreements and disagreements with other
studies or reviews
Our results are consistent with themost recent evidence-based rec-
ommendations for the use of NPWT, which cover a range of ap-
plications, including NPWT for acute wounds (Krug 2011). One
systematic review,Ubbink 2008, was published before seven of our
included trials were undertaken and included an earlier trial that
we excluded from our review (Moisidis 2004), so results are not
comparable. However, our findings differ from those of two recent
systematic reviews, which evaluated the effectiveness ofNPWT for
incisional wounds. Important differences in the inclusion criteria
account for the differences: the first included 10 RCTs and five
observational studies (Ingargiola 2013), and the second included
33 publications (Karlakki 2013), seven of which were RCTs, with
the remaining publications consisting of a combination of non-
comparative case series, comparative cohort studies and compar-
ative laboratory studies. Neither author included trials that had
used ’home-made’ devices. Authors from the Karlakki 2013 trial
disclosed conflicts of interest, all benefiting from funding from the
manufacturer of the NPWT device. Both of these reviews found
in favour of NPWT for reducing surgical site infection (SSI) and
other negative wound outcomes. Consequently, the issue of man-
ufacturer sponsorship in studies of healthcare products remains.
Specifically, a review of the effect of manufacturer involvement on
studies of negative pressure wound therapy showed that 19 of the
24 studies reviewed had manufacturer involvement. Importantly,
18 of the 19 studies showed a positive effect for themanufacturer’s
product, while one was ’impartial’ (Kairinos 2014). However, our
findings are in agreement with other non-randomised studies that
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show that NPWT may reduce skin graft complications (Blume
2010; Kim 2007). Other randomised (Hu 2009) and non-ran-
domised studies have also shown a marked cost benefit when non-
commercial applications were compared with commercial prod-
ucts (Rozen 2008; Shalom 2008). In one of these studies, a net
saving per patient was USD 2603 (Rozen 2008).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence about whether negative pressure wound therapy
(NPWT) reduces surgical site infection or wound dehiscence re-
mains unclear, as does its effect on time to complete healing. Rates
of graft loss may be lower when NPWT is used. Machines and
systems that are designed and built within hospitals are as effective
in this area as commercial products. There are clear cost benefits
when non-commercial systems are used to create the negative pres-
sure required for wound therapy, with no evidence of worsening
of clinical outcome. Pain levels are also rated lower when hospital-
designed systems are used compared with their commercial coun-
terparts. The high incidence of blisters occurring when NPWT
is used following orthopaedic surgery suggests that the therapy
should be limited until safety in this population is established.
Implications for research
There is an urgent need for suitably powered, high-quality trials
to evaluate the effectiveness of the newer NPWT products, which
are designed for use on closed clean surgical incisions. Such trials
should focus initially on wounds that may be difficult to heal, such
as sternal wounds or incisions on obese patients. Given the large
cost differences between products, further trials comparing differ-
ent types of NPWT are also justified. Full economic evaluations,
including those associated with the NPWT system itself, special-
ist and other practitioner costs as measured by time or number
of visits, potential cost-savings from a change in the number of
bed days in hospital, and costs stemming from differing rates of
adverse events and complications (including procedures initiated
due to the failure of wounds to heal, such as amputation) need to
be included. This will enable users of any future review to gain a
clear understanding of the nature of resource use associated with
negative pressure wound therapy. To facilitate assessment, future
trials that combine different types of conditions (acute, sub-acute
and chronic) should present results of each condition group sep-
arately. It may also be useful to test NPWT at various pressures.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chio 2010
Methods Study design: randomised controlled trial
Ethics and informed consent: ethics approved and consent obtained
Sample size calculation: yes
ITT analysis: participants analysed in groups to which they were assigned but 4 partic-
ipants, who did not present for follow-up, were not included in the analysis
Participants Location: Columbus, Ohio, USA
Intervention group: n = 27;Control group 2: n = 27
Mean age: Intervention group = 62.1 years;Control Group 2 = 58.1 years
Inclusion criteria: patients scheduled to undergo radial forearm free flap
Exclusion criteria: none stated
Interventions Aim/s: to evaluate the effectiveness of negative pressure dressings compared with static
pressure dressings in the prevention of graft failure
Intervention/s in both groups: Quote “In all subjects, iodine petroleum-impregnated
gauze rolls were placed over the skin graft in the inter-tendon spaces, followed by coverage
with a sheet of Adaptic nonadherent dressing (Johnson & Johnson, Langhorne, PA)
. Dressings in both treatment groups were left in place for a total of six days, after
which all dressings were then taken down, and the donor site dressed with Adaptic and
circumferential gauze roll for a total of two weeks”
Group 1 (NPD) intervention: Quote “foam specifically designed for use with the nega-
tive pressure device (V.A.C. device; KCI, San Antonio, TX) was cut and the arm covered
with an occlusive dressing. The vacuum device was attached and activated intraopera-
tively and set to -125 mmHg with adequate seal verified. No immobilizing splint was
used”
Group 2 (SPD) intervention: Quote “a piece of sterile surgical foam cut to size and
wrapped in Adaptic dressing was secured over the recipient bed followed by placement
of a volar wrist-immobilizing splint”
Study date/s: March 2007-August 2009
Outcomes • Graft failure
• Percentage of area of skin graft failure
• Adverse events
Validity of measure/s: quantitative measurements of the donor site were accomplished
with the aid of a 1 x 1 cm grid transparency, which was laid over the donor site. The
exact borders of the skin graft were then traced onto the overlying grid with a permanent
marker
Time points: follow-up at 2 weeks post surgery (NB graft failure was also measured at
1 month post surgery but it was unclear if those from the 2-week follow-up had been
included in this measure)
Notes
Risk of bias
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Chio 2010 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote “A randomization sched-
ule, created by a biostatistician using a ran-
dom number generator”
Comment: blocking not mentioned
Allocation concealment (selection bias) High risk Evidence: Quote “We had a list of the ran-
domization schedule, andpts [participants]
were assigned to either group based on
the order of their surgery” (personal, email
communication)
Comment: surgeons aware of the next as-
signment
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Evidence for participants: not possible
Comment: unlikely to affect outcomes
Evidence for personnel: not possible
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Evidence: Quote “Evaluators at the time of
the postoperative visits were not blinded
as to which treatment arm the subjects be-
longed”
Comment: correspondence with the au-
thor confirmed that “evaluators” were in-
vestigators
Incomplete outcome data (attrition bias)
All outcomes
High risk Evidence: Quote“Four subjects 4/54 (all
of whom belonged to the NPD group)
were lost to the first postoperative follow-
up and were thus excluded from final anal-
ysis because no postoperative data could be
recorded for these subjects. Of the remain-
ing 50 subjects, only 32 patients (16 sub-
jects in SPD group and 16 subjects in NPD
group) returned for their second postoper-
ative visit”
Comment: only data from the first post-
operative visit have been included
Unequal distribution of ’drop outs’ (15% in
negative pressure group; 0% in static pres-
sure group)
Selective reporting (reporting bias) Low risk Comment: all the pre-specified clinical
outcomes were presented in Table 2 of the
trial report. Adverse events were reported
in the Results section of the trial report.
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Chio 2010 (Continued)
Measures reflect the aims of the interven-
tion and the pre-defined outcomes. A pub-
lished protocol was not available
Other bias Low risk Evidence: the authors report: Quote
“Competing interests: None. Sponsor-
ships: None”
Comment: no other potential biases were
identified
Crist 2014
Methods Study design: randomised controlled trial
Ethics and informed consent: ethics approved and consent obtained
Sample size calculation: not stated
ITT analysis: available case analysis
Participants Location: Columbia, USA
Intervention group: n = 55;Control group: n = 60
Mean age: Intervention group = 47.2 years (SD 19.6);Control group = 48.3 years (SD
20.1). Data extracted from results section of clinicaltrials.gov (NCT00635479)
Inclusion criteria: patients that underwent an open surgical exposure for hip, pelvis, or
acetabular fracture
Exclusion criteria: none stated
Interventions Aim/s
Primary : to determine the effectiveness of using NPWT over primarily closed surgical
incisions used for open reduction and internal fixation of hip, pelvis, and acetabular
fracture surgery
Secondary :
Group 1 (NPC) intervention: Quote “negative pressure dressing applied over the pri-
marily closed incision sterilely in the operating room. NPWT was left on for 2 days or
longer if drainage continued.”
Group 2 (Control) intervention: Quote “standard gauze dressing”. The ’standard dress-
ing’ was not described
Study date/s: not provided
Outcomes • Infection
• LOS
• Total serious adverse events
Validity of measure/s: not provided
Time points: followed for 12 months
Notes Conference abstract. Additional information provided by the investigator and from a
search of clinicaltrials.gov (NCT00635479)
Risk of bias
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Crist 2014 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote “Computer randomiza-
tion”
Comment: correspondence with author
Allocation concealment (selection bias) Low risk Evidence: Quote “Opaquesealed envelope
opened in the OR”
Comment: correspondence with author
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Evidence for participants: not possible
Comment: unlikely to affect outcomes
Evidence for personnel: not possible
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Evidence: Quote “Yes”
Comment: correspondence with author
Incomplete outcome data (attrition bias)
All outcomes
High risk Evidence: Quote “55 patients randomized
to the NPWT group and 60 patients ran-
domized to the standard dressing group.
The NPWT group included 49 patients
and the gauze group included 42 patients
that completed the 12 month follow-up.”
Comment: 10.9% patients in NPWT
group and 30.0% of control group were
lost to follow-up
Selective reporting (reporting bias) Low risk Comment: protocol registered onClinical-
Trials.gov with identifier: NCT00635479.
Expected outcomes were reported in the
abstract, but other outcomes nominated in
the protocol were not reported (such as to-
tal serious adverse events). These may be
included when the full trial is published
Other bias Unclear risk Evidence: Quote “Two of the authors have
been advisory consultants for KCI and
have previously received research funding
for different projects. This study was not
funded by KCI.”
Comment: correspondence with author
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Dorafshar 2011
Methods Study design: randomised controlled trial
Ethics and informed consent: ethics approved and consent obtained
Sample size calculation: yes
ITT analysis: yes
Participants Location: University of Chicago Medical Center, IL, USA
Intervention group: n = 42;Control group: n = 45
Mean age: Group 1 = 53 years;Group 2 = 54 years
Inclusion criteria: patients admitted to University of Chicago Medical Center,18 years
of age and over, with acute wounds resulting from trauma, dehiscence, or surgery
Exclusion criteria:
• systemic sepsis caused by wound infection;
• grossly necrotic wounds;
• malignancy in the wound;
• wounds with untreated osteomyelitis;
• patients with allergy to sulfamylon and Dakin’s (sodium hypochlorite) solution;
• patients with severe peripheral vascular disease.
Interventions Aim/s: Quote ”The primary objective was to compare the efficacy of VAC and GSUC
with respect to changes in wound size. Secondary objectives were to compare associated
costs of the dressings, the ease of application, and the pain associated with each dressing
change“
Intervention/s in both groups: Quote ”Patients had ad lib access to analgesics admin-
istered via PCA or a nurse“
Group 1 (GSUC) intervention: Quote ”In the GSUC arm, a gauze dressing (Kerlix 4.
5 inch roll, Covidien, Mansfield MA) moistened with 0.9% normal saline was applied
to the wounds, a red rubber catheter (CR Bard, Covington, GA) was placed in the
center of the dressing, and the dressing was then sealed with an occlusive cover (Ioban
Antimicrobial Incise Drape, 3M, St Paul, MN). Continuous wall suction at - 75 to - 80
mm Hg was applied and the dressings were changed daily“
Group 2 (VAC) intervention: Quote ”In the VAC arm, GranuFoam black sponge (KCI,
San Antonio, TX) was applied to the wounds and sealed with an occlusive plastic cover;
continuous suction at - 75 to - 125 mm Hg was initiated and the dressing was changed
every 48 hours, as recommended by VAC therapy guidelines. All components of the
dressing were obtained from Kinetics Concepts, Inc“
Study date/s: October 2006-May 2008
Outcomes • Rate of change in surface area between groups (expressed as the rate of change %/
day)
• Rate of change in wound volume between groups (expressed as the rate of change
%/day)
• Cost/day
• Pain measured using a 0 to 10 linear analogue scale and reported as the ”sum of
pain intensity differences“
• Wound complications
• Adverse events
Validity of measure/s
• ”Wound size was calculated using the Xakellis and Frantz method: wound surface
area = length X width X 0.783; wound volume area = area X depth X 0.327“
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Dorafshar 2011 (Continued)
• Pain was self-reported and measured ”according to the 0 to 10 linear analogue
scale immediately before, during, and after removal of the dressing. The sum of pain
intensity differences (SPID) was used to facilitate comparison of pain levels between
the 2 groups. The SPID score was calculated using the formula: (pain during - pain
before) + (pain after - pain during).“
Time points: data collected up to day 7 were included in the analyses
Notes The intervention was a ’home made’ device.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote ”The randomization se-
quence was generated from the Web site
http://www.randomization.com“
Comment: blocking not mentioned
Allocation concealment (selection bias) Unclear risk Evidence: Quote ”On enrolment, patients
were then randomized to either GSUC or
VAC therapy in a 1:1 ratio by drawing a
previously prepared card“
Comment: unclear whether the allocations
on the previously prepared cardwere visible
before allocation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Evidence for participants: Quote ”The 2
methods of SAWT were obviously and vis-
ibly different, so it was impossible to blind
either the therapists or the patients to the
method of treatment“
Comment: unlikely to affect outcomes
Evidence for personnel: Quote ”The 2
methods of SAWT were obviously and vis-
ibly different, so it was impossible to blind
either the therapists or the patients to the
method of treatment“
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Evidence: Quote ”A senior therapist who
was highly experienced with both VAC and
GSUC changed all of the dressings. We
tried to minimize bias by using therapists
who were not participating in the study to
gather and record data”
Comment: the therapist was not blinded
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Dorafshar 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Evidence: Quote “An intention-to-treat
analysis was performed for all of the pri-
mary and secondary outcomes. Forty-five
patients in the GSUC group and 42 pa-
tients in the VAC group were included in
the analyses.”
Selective reporting (reporting bias) Low risk Comment: all the pre-specified clinical
outcomes were presented in Tables 3 and
4 in the trial report. Complications and
adverse events were reported in the results
section of the trial report. We accessed the
published protocol (NCT00724750) and
confirmed that the aims of the study and
the pre-defined outcomes listed in the pro-
tocol were the same as in the published pa-
per
Other bias Unclear risk Evidence: the study began in 2006 but the
protocol was Quote “First Received on July
25, 2008” at ClinicalTrials.gov
Comment: potential for study characteris-
tics to have changed before or during the
study
Howell 2011
Methods Study design: randomised controlled trial
Ethics and informed consent: not reported
Sample size calculation: yes
ITT analysis: all participants completed the study
Participants Location: NYU Hospital for Joint Disorders, New York, NY, USA
Intervention group: n = 24;Group 2: n = 36
Mean age: not reported
Inclusion criteria: patients undergoing unilateral or bilateral primary total knee arthro-
plasty who were obese (BMI > 30), who met criteria of increased risk for postoperative
wound drainage and who were prescribed enoxaparin sodium for deep vein thrombosis
prophylaxis
Exclusion criteria: patient refusal to participate in the study, revision total knee replace-
ment, prior knee surgery (except arthroscopy), and patients with documented diabetes
mellitus
Interventions Aim/s: to compare the number of days to dry wound in a negative pressure dressings
group compared with a static pressure dressings group
Intervention/s in both groups: Quote”All patients received three doses of peri-operative
intravenous antibiotics and were maintained on subcutaneous DVT prophylaxis for 30
days after surgery“
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Howell 2011 (Continued)
Group 1 (NPD) intervention: Quote ”Subsequent to the closure of the surgical incision,
a negative pressure dressing (VAC Therapy, Kinetic Concepts Inc., San Antonio, Texas)
was applied under sterile conditions. A medical grade open cell polyurethane ether foam
(pore size of 400--600 micrometers) was cut into the shape of a rectangle approximately
5 cm in width and a length sufficient to cover the entire linear wound. The knee was
held in 151 of flexion, and the foam was secured over the incision by the application of
a specialized adhesive drape, provided in the VAC Therapy system. An evacuation tube
with side ports was embedded within the reticulated foam, allowing negative pressure
to be applied equally over the entire wound bed. The foam-evacuation tube complex
attached to a programmable vacuum pump applied a - 125 mmHg continuous vacuum
pressure to the wound. The VAC Therapy dressing remained in place for a 48-hour
period, after which time clean, dry gauze dressings were applied and changed on daily
basis until the wound was dry“
Group 2 (SPD) intervention: ”Patients in the control arm had their surgical wound
covered in the operating room with a sterile, dry gauze dressing that was held in place
with a perforated, stretchable cloth tape. This initial dressing remained in place for 48
hours after which time clean, dry gauze dressings were applied and changed on a daily
basis until the wound was dry.“
Study date/s: not stated
Outcomes • Days to dry wound
• Deep wound infection
• Blister formation
Time points: patients followed up for 12 months post surgery
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: not described
Allocation concealment (selection bias) Low risk Evidence: Quote
“randomized with blinded envelopes to ei-
ther the treatment with negative pressure
wound therapy group or a control group
using sterile gauze”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Evidence: not described
Comment: difference in appearance of
dressings made blinding impossible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Evidence: not described
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Howell 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Evidence: 51 patients were randomised
and 51 completed the study
Selective reporting (reporting bias) Low risk Comment: the pre-specified clinical out-
comes were presented in Table 1 in the trial
report and a post hoc analysis of blister oc-
currence was shown in Table 2. Infection
rates were reported in the results section of
the trial report. We could not find a pub-
lished protocol
Other bias High risk No baseline data were presented. In addi-
tion, groups contained unequal numbers,
which may indicate undisclosed losses in
one group
The study was supported by KCI, theman-
ufacturer of the negative pressure device
Llanos 2006
Methods Study design: randomised, double-blind controlled trial
Ethics and informed consent: ethics approved and consent obtained
Sample size calculation: yes
ITT analysis: yes
Participants Location: Burn & Plastic Surgery Unit, Santiago, Chile
Intervention group: n = 30;Control group: n = 30
Mean age: Intervention group = 34 years (range 20-52);Control group = 34.5 years
(range 19-58)
Inclusion criteria: Quote “all patients who were admitted at the hospital with acute
traumatic injuries and skin loss, which hindered primary closure, underwent a surgical
cleaning of their wound, and had a quantitative biopsy culture performed on their
wound. Those patients whose biopsy culture had a bacterial count lower than 100,000
colony forming units per gram of tissue and who had given informed consent to enter
the study were recruited”
Exclusion criteria: thosewho,Quote “hadburns that covered 20%, ormore, of their total
body surface; were polytraumatized; had surgical contraindications because of medical,
anesthetic (serious associated pathology), or surgical cause (hypoalbuminemia or systemic
infection); or were enlisted in other clinical trials”
Interventions Aim/s
Primary : to determine if the negative pressure closure diminishes the area loss of the
skin grafts
Secondary : to determine if:
• the negative pressure closure shortens hospital stay, or whether secondary wound
coverage procedures are needed; and
• to determine whether there is a relation between the area loss of the skin graft and
the total grafted surface
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Llanos 2006 (Continued)
Intervention/s in both groups: Quote“The graft was covered with a single layer of paraf-
fin gauze dressing (Jelonet, Smith & Nephew, England); then, 3 sheets of polyurethane
(high-density foam, Nuris Luisa, Santiago, Chile) with a fenestrated silicone drainage
tube between the layers was placed over the gauze and covered with a transparent adhe-
sive dressing (Op site, Smith & Nephew) providing the vacuum seal. We used a double
layer under the tube to prevent pressure ulcers at the bed of the suction tube.”
Group 1 (NPC) intervention: Quote “The suction tube was connected to the central
aspiration system at a pressure of -80 mm Hg, and the integrity of the vacuum seal was
tested and reinforced with cotton dressing and an elastic gauze bandage if necessary”
Group 2 (Control) intervention: the control groupQuote “only differed from the active
group in that it lacked a connection to the central aspiration system (i.e., negative pressure
vacuum)”
Study date/s: May 2003-October 2004
Outcomes • Area loss of skin graft in cm2
• Need for re-grafting
• Length of hospital stay
• Complications
Validity of measure/s: Quote “Digital photographs, without flash, were taken from
a distance of 40 cm from the wound to evaluate the areas of loss at the moment of
uncovering the graft. Afterward, these images were analyzedwith the Autocad (Autodesk,
Inc, 2001, Fremont, CA) software, measuring the loss in cm2”
Time points: fourth postoperative day
Notes The intervention was a ’home made’ device.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote “Treatment assignment
was performed using computer-generated
random numbers in permuted blocks of 6”
Allocation concealment (selection bias) High risk Evidence: Quote “The treatment allocation
of each patient was performed by the nurse
of the operating room who knew the cor-
responding assignment”
Comment: follow-up correspondencewith
the author indicated Quote “the theatre
nurse had a list of randomizationwith com-
puter generated random numbers”, so allo-
cation was not concealed
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Evidence for participants: not described
Comment: dressings were identical. The
only difference was that dressing in the
NPC group were connected to an ’active’
suction device. Potential for participant to
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Llanos 2006 (Continued)
notice this
Evidence for personnel: Quote “The corre-
sponding treatment was notified to the sur-
geon only once the skin graft had been per-
formed so that the surgeon did not modify
his technique according to the assignation
of treatment”
Comment: once surgery was completed,
other personnel would have been aware of
group assignment (active suction or not)
. Whether this would have affected out-
comes is unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Evidence: Quote “The person in charge of
measuring the areas in the photographic
register was masked to which intervention
the patient had received. That way, at the
moment of evaluating the photograph, this
person did not know whether or not the
patient had undergone NPC. In addition,
the data analyst was masked to the groups
of intervention at the moment of analyzing
the results”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Evidence: Quote “All the patients were an-
alyzed in the group to which they were as-
signed, adhering to the intention-to-treat
principle” and “In our study, there were no
drop-outs, drop-ins, or noncompliant pa-
tients. Furthermore, no patients refused to
take part in the study”
Selective reporting (reporting bias) Low risk Comment: all the pre-specified clinical
outcomes were presented in Table 2 and in
Figures 4 and 5 in the trial report. Adverse
events were reported in the results section.
Outcome measures reflected the aims of
the intervention and the pre-defined out-
comes. A published protocol was not avail-
able
Other bias Low risk Evidence: Quote “The authors have no
conflicts of interest with any of the manu-
facturing companies of the products used
in the present study”
Comment: no other potential biases were
identified
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Masden 2012
Methods Study design: randomised controlled trial
Ethics and informed consent: the study was approved by the Georgetown University
Institutional Review Board. Consent was not specifically stated, but those patients not
capable of undergoing informed consent were excluded
Sample size calculation: yes
ITT analysis: Available case analysis
Participants Location: Columbus, Ohio, USA
Intervention group: n = 50;Control group: n = 43
Mean age: Intervention group = 61.3 years (range 40 - 101);Control group = 61.3
years (range 38 - 86)
Inclusion criteria: patients scheduled to undergo radial forearm free flap
Exclusion criteria: Quote”patients not capable of undergoing informed consent and
those patients with tape allergies or who otherwise could not tolerate NPWT . . . patients
with lower extremity amputations distal to the forefoot were excluded.“
Interventions Aim/s
Primary : Quote ”to evaluate the effectiveness of NPWT in patients with multiple co
morbidities“
Secondary : Quote ”to evaluate factors that contribute to wound complication
Intervention/s in both groups: Quote“The graft was covered with a single layer of paraf-
fin gauze dressing (Jelonet, Smith & Nephew, England); then, 3 sheets of polyurethane
(high-density foam, Nuris Luisa, Santiago, Chile) with a fenestrated silicone drainage
tube between the layers was placed over the gauze and covered with a transparent adhe-
sive dressing (Op site, Smith & Nephew) providing the vacuum seal. We used a double
layer under the tube to prevent pressure ulcers at the bed of the suction tube.”
Group 1 (NPWT) intervention: Quote “NPWT group, which underwent placement
of a V.A.C. system (KCI, San Antonio, TX) along the line of closure set at−125mmHg
continuous pressure at the time of closure
Group 2 (Control) intervention: Quote ”the control group, which received a standard
dry sterile dressing consisting of a non adhesive silicone layer (Mepitel;MölnlyckeHealth
Care AB, Göteborg, Sweden) and a bacteriostatic single silver layer (Acticoat, Smith &
Nephew, Hull, United Kingdom).
Study date/s: October 2008 - August 2010.
Outcomes • Wound infection
• Dehiscence
• Re-operation
• LOS
Validity of measure/s: not stated
Time points: Quote “all incisions assessed on the third postoperative day . . . and re-
assessed at the first outpatient postoperative visit, as well as any subsequent visit (the
last recorded infection was at 66 days post surgery).” However, the abstract stated that
“Average follow-up was 113 days”
Notes
Risk of bias
34Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Masden 2012 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote (from correspondence with
the author) “Used a randomization gener-
ator through Excel in groups of 8 (4 con-
trols, 4 experimental)”
Comment: adequate method
Allocation concealment (selection bias) Low risk Evidence: Quote (from correspondence with
the author) “ When the patient was re-
cruited . . . they contacted one of the in-
vestigators and the patient was assigned to
whichever group was next on the list”
Comment: adequate method
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Evidence for participants: not possible
Comment: unlikely to affect outcomes
Evidence for personnel: not possible
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Evidence: Quote “The evaluations were
performed by a member of the research
team not involved in the enrolment or the
operative treatment and, thus, were blinded
as to randomization group”
Comment: adequate method
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Evidence: Quote “Twelve subjects were lost
to followup in the immediate postoperative
period and were excluded from the final
analysis”
Comment: equal number of losses in both
groups
Selective reporting (reporting bias) Low risk Comment: protocol unavailable, but ex-
pected outcomes reported
Other bias High risk Evidence: Quote “Drs Attinger and Stein-
berg are consultants for Kinetic Concepts
Incorporated”
Comment: study funded by manufacturer.
Also, the control group received co-inter-
vention - a bacteriostatic single silver layer
(Acticoat, Smith & Nephew, Hull, United
Kingdom) with their dressing
35Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pachowsky 2011
Methods Study design: randomised controlled trial
Ethics and informed consent: ethics approved and consent obtained
Sample size calculation: no
ITT analysis: yes
Participants Location: University hospital in Erlangen, Germany
Intervention group: n = 9;Control group: n = 10
Mean age: Intervention group = 66.2 years (SD 17.83);Control group = 70.0 years
(SD 11.01)
Inclusion criteria: Quote ”consecutive patientswhowere scheduled for a total hip arthro-
plasty (THA) for osteoarthritis of the hip were randomised“
Exclusion criteria: not stated
Interventions Aim/s
Primary : Quote: ”to evaluate the effect of NPWT on postoperative seroma“
Secondary : Quote ”to evaluate any potential influence wound healing and laboratory
inflammatory values.
Intervention/s in both groups: Quote“The surgical intervention was identical for both
groups. All patients received two Redon drains, one in the deep area of the wound
close to the prostheses and one above the closed fascia. The postoperative physiotherapy
and mobilisation was also identical for both groups. Both groups received perioperative
prophylaxis with antibiotics either Augmentin (amoxicillin trihydrate with potassium
clavulanate) or ciprofloxacin”
Group 1 (NPWT) intervention: Quote “The NPWT group was treated with a PRE-
VENA™ system (KCI, San Antonio, USA). The PREVENA system was left on the
wound for five days including the day of surgery.”
Group 2 (Control) intervention: the control group receivedQuote “the standardwound
dressing of our department, consisting of a dry wound coverage”
Study date/s: not stated
Outcomes • Incidence of seroma (by ultrasound)
• Amount of wound drainage in the Redondrain canisters
• Duration of prophylactic antibiotics
• Secretion from the wound
Validity of measure/s: Quote “All patients underwent an ultrasound (Zonare, Z.one
Ultra SP 4.2, Erlangen, ZONAREMedical Systems, Inc., Mountain View, USA) of the
wound”
Time points: fifth and tenth post-operative days
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated
Allocation concealment (selection bias) Unclear risk Not stated
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Pachowsky 2011 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Evidence for participants: not possible
Comment: unlikely to affect outcomes
Evidence for personnel: not possible
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Dressings were left in place for 5 days. The
ultrasound was performed on day 5. It was
unclear if the person performing the ultra-
sound was aware of the allocated group
Incomplete outcome data (attrition bias)
All outcomes
Low risk All enrolled patients were accounted for in
the analyses
Selective reporting (reporting bias) Unclear risk Results for outcomes identified in the
methods section were reported.We did not
see the original protocol
Other bias Unclear risk Evidence: Quote “Matthias H. Brem gave
scientific presentations for KCI. The PRE-
VENATM wound treatment system was
provided by KCI free of charge.”
One patient in the NPWT group removed
the Redon drain by himself on the first
postoperative day
Petkar 2012
Methods Study design: randomised controlled trial
Ethics and informed consent: yes
Sample size calculation: no
ITT analysis: all enrolled patients included in analysis
Participants Location: plastic and reconstructive surgery department of a tertiary referral centre
Vellore, Tamil Nadu, India
Intervention group: n = 35;Control group: n = 36
Mean age: Intervention group 1 = 35.1 years;Control group 2 = 34.1 years
Inclusion criteria: patients undergoing split-skin grafting
Exclusion criteria: a known bleeding tendency, repeat grafting for a failed graft and
regions which were technically not amenable for application of vacuum closure, e.g. oral
commissure, eyelids and hairy scalp in patients unwilling for head tonsuring
Interventions Aim/s
Primary : to assess the effectiveness of NPWT over standard dressings in this population
Secondary : None stated
Intervention/s in both groups: Quote ”The patients were operated by plastic surgery
consultants and registrars of a single unit. Soon after the placement of the graft and
securing it with staplers or catgut sutures as necessary“
Group 1 (NPC) intervention: Quote ”only Vaseline gauze was laid on the graft, on
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Petkar 2012 (Continued)
which a low-density polyurethane foam of 1.5-in.-thickness cut to the size of the graft
was placed. A soft, flexible transparent plastic or silicone tube of 5-mm inner diameter
and 1 meter length was fenestrated at sides near one of the ends and the same was
inserted into the foam by making a shallow slit in the latter. The assembly was covered
with a transparent adhesive film (Opsite) whose edges were fastened to the normal skin
surrounding the dressing to create an airtight seal. Outer end of the tube was then
connected to a continuous wall suction of - 80 mm Hg when the patient was shifted
from the operation theatre“
Group 2 (Control) intervention: Quote ”In the control group, a Vaseline gauze was
placed over the graft, cotton bandages were placed and were secured with roller gauze
bandage, elastic adhesive bandage or tie-over dressing as deemed necessary in a conven-
tional dressing.“
Study date/s: May 2003-October 2004
Outcomes • Graft failure
• Percentage of area of skin graft failure
• Adverse events
Validity of measure/s: quantitative measurements of the donor site were accomplished
with the aid of a 1 x 1 cm grid transparency, which was laid over the donor site. The
exact borders of the skin graft were then traced onto the overlying grid with a permanent
marker
Time points: follow-up at 2 weeks post surgery (NB graft failure was also measured at
1 month post surgery but it was unclear whether those from the 2-week follow-up had
been included in this measure)
Notes The intervention was a ’home made’ device.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote ”Each wound was ran-
domized into study or control group using
anopen list of computer-generated random
numbers.“
Comment: adequate method
Allocation concealment (selection bias) High risk Evidence: Quote ”Each wound was ran-
domized into study or control group using
anopen list of computer-generated random
numbers“
Comment: as some patients hadmore than
one graft wound, it would have been pos-
sible, using an open randomisation alloca-
tion, to select the intervention for a specific
wound
Blinding of participants and personnel
(performance bias)
Low risk Evidence for participants: not possible
Comment: unlikely to affect outcomes
38Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Petkar 2012 (Continued)
All outcomes Evidence for personnel: not possible
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Evidence: Quote ”Percentage of graft take
was assessed by gross examination on day
9 and then day 14 by the consultants in
treating plastic surgery unit of the grade of
professor.“
Comment: unclear whether assessors were
aware of group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: all randomised wounds were
reported in results
Selective reporting (reporting bias) Unclear risk Evidence: Quote ”the patient was asked to
discontinue the dressing or was decided to
undergo re-surgery at the site”
Comment: protocol not viewed. Infection
not reported. Patients may have undergone
further surgery at the location of grafting,
but this was not reported in the paper
Other bias Unclear risk Comment: wounds, not people were ran-
domised (unit of analysis error)
Stannard 2012
Methods Study design: multi-centre, randomised controlled trial (4 Level one trauma centres)
Ethics and informed consent: ethics approved and consent obtained
Sample size calculation: no
ITT analysis: wounds, not people were assessed
Participants Location: Columbus, Ohio, USA
Intervention group: n = 130 participants; 141 fractures;Control group: n = 119 par-
ticipants; 122 fractures
Mean age: Intervention group not stated;Control group 2 not stated
Inclusion criteria: people > 18 years of age, who sustained a high-energy tibial plateau,
pilon or calcaneus fracture were able to comply with research protocol and willing to
give informed consent
Exclusion criteria: nonoperative calcaneus, tibia plateau, or pilon fractures; patients
with open calcaneus fractures; tibial plateau or calcaneus fractures receiving definitive
surgery more than 16 days after injury; pilon fractures receiving definitive surgery more
than 21 days after injury; prisoners; pregnant women; patients with one of these fractures
as a result of a low-energy mechanism of injury; patients or family members unable
or unwilling to sign study informed consent; and patients unable to comply with the
protocol
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Stannard 2012 (Continued)
Interventions Aim/s
Primary : Quote “to investigate the use of NPWT to prevent wound dehiscence and
infection after high-risk lower extremity trauma
Secondary : None stated
Intervention/s in both groups: dressings or NPWTwere applied in the operating room
and then changed on postoperative day 2 and every 1 to 2 days thereafter
Group 1 (NPC) intervention: NPWT over the surgical incision after open reduction
and internal fixation of the fracture
Group 2 (Control) intervention: standard post operative dressing (dressing not de-
scribed)
Study date/s: not stated
Outcomes • Wound infection and dehiscence
• Time to discharge from hospital
Validity of measure/s: Quote ”All infections were confirmed with cultures“
Time points: Not stated - unclear for how long patients were followed-up
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Evidence: Quote ”Patients were enrolled
and then randomized to receive either stan-
dard postoperative dressings (control) or
NPWT (study)“
Comment: additional author information
“the randomization was done via a com-
puter generated randomization program”
Allocation concealment (selection bias) Unclear risk Comment: method not clarified
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Evidence for participants: not possible
Comment: unlikely to affect outcomes
Evidence for personnel: not possible
Comment: unlikely to affect outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Evidence: Quote “A patient was diagnosed
as having an infection when a combina-
tion of clinical signs and symptoms (puru-
lent drainage, erythema, fever, chills, etc)
and laboratory data documented the infec-
tion. All infections were confirmed with
cultures. Wound dehiscence was defined as
any separation of the surgical incision that
required either local wound care or surgical
treatment”
40Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Stannard 2012 (Continued)
Comment: not clear whether those assess-
ing outcomes were aware of group assign-
ment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: a total of 249 patients were
recruited. The same number of patients
were reported for both acute and long term
follow-up (follow-up period not defined).
Given that 4 hospitals were involved in the
study, it seems unusual that complete fol-
low-up would have occurred; suggesting an
available case analysis may have been per-
formed
Selective reporting (reporting bias) Low risk Evidence: Quote “NCT00582998”
Comment: registered 9 months after final
data collection date, so unclear whether re-
ported outcomes match original protocol.
However, infection and dehiscence were
the expected outcomes
Other bias High risk Evidence: Quote “Funds from corporate/
industry were received from Kinetic Con-
cepts, Inc to support this work. Each insti-
tution received benefits directed solely to a
research fund, foundation, educational in-
stitution, or other nonprofit organization
which the author(s) has/have been associ-
ated.One ormore of the author(s) has/have
received or will receive benefits for personal
or professional use froma commercial party
related directly or indirectly to the subject
of this manuscript: honoraria and consul-
tancy”
Comment:
• Unequal number of participants in
each group
• Appears from the protocol that data
collection was over many years, but no
dates or explanation in manuscript
• Results reported per fracture so there
is a potential unit of analysis issue
Abbreviations
BMI: body mass index
DVT: deep venous thrombosis
GSUC: (no definition, apart from stating it was similar to another hospital developed device (a subatmospheric pressure wound therapy
system; SAWT)
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ITT: intention-to-treat
KCI: Kinetic Concepts Incorporated
LOS: length of stay
NPC: negative pressure closure
NPD: negative pressure device
NPWT: negative pressure wound therapy
OR: operating room (theatre)
PCA: patient controlled analgesia
SAWT:subatmospheric pressure wound therapy system
SPD: static pressure dressing
SPID: sum of pain intensity differences
TKR: total knee replacement
TKA: total knee arthroplasty
VAC: vacuum assisted closure
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Albert 2012 No acute wounds were included
Banasiewicz 2013 Included infected wounds
Bondoki 2011 Prospective cohort study
Braakenburg 2006 Chronic and acute wounds were reported together and further information was not available
Eisenhardt 2012 None of our outcomes of interest were included
Grauhan 2013 Alternate allocation at time of surgery was used for group allocation
Hu 2009 Acute, sub-acute and chronic wounds were included. Acute wounds were defined as those that had been ’open’
for less than 1 week
Johannesson 2008 The intervention dressing was not a continuous negative pressure device
Kim 2007 The study was not a randomised controlled trial
Moisidis 2004 None of our pre-defined outcomes were reported. No objective measure of graft failure used. Half of the wounds
were chronic
Moues 2004 No acute wounds were included
Moues 2007 No acute wounds were included
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Characteristics of studies awaiting assessment [ordered by study ID]
Mullins 2012
Methods A health economic model
Participants Patients enrolled in a randomised controlled trial of patients receiving negative pressure wound therapy over clean,
closed surgical incisions (Stannard 2012)
Interventions Hypothetical economic model applied national cost dollars to clinical outcomes of the Stannard 2012 trial
Outcomes Potential per patient cost savings of $5338 for infection and $1586 for dehiscence
Notes Conference paper. Waiting for publication with further details about methods
Characteristics of ongoing studies [ordered by study ID]
Chan 2011
Trial name or title A prospective randomised controlled trial of negative pressure suction dressing and early mobilisation in the
management of lower leg skin grafts
Methods Randomised controlled trial
Participants Patients with lower leg wounds requiring split skin grafting for primary closure, e.g. post planned skin lesion
removal or trauma
Interventions Negative pressure dressing versus static pressure dressing
Outcomes Primary: graft success at day 5 to 7 when dressing is removed. Secondary: graft success at 6-week follow-up
Starting date Early 2011
Contact information Mark.Wade@waitematadhb.govt.nz; richard.martin@waitematadhb.govt.nz
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Negative pressure wound therapy versus standard dressing
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Surgical site infection 3 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Incisional wound 3 232 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.41, 2.54]
2 Surgical site infection using
wound, not individual, as
denominator
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Dehiscence 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Dehiscence using wounds, not
individual, as denominator
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
5 Re-operation 3 212 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.34, 1.05]
5.1 Incisional wounds 1 81 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.41, 2.20]
5.2 Skin grafts 2 131 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.19, 0.92]
6 Seroma/haematoma 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
6.1 Wounds 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Graft failure at 2 weeks 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8 Skin blisters 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. Non-commercial NPWT versus commercial NPWT device
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Seroma/haematoma 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Wounds 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Comparison 3. Non-commercial NPWT versus standard care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Re-operation 2 131 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.19, 0.92]
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Comparison 4. Funded versus non-funded or unknown funding
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Any outcome 9 785 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.52, 0.87]
1.1 Manufacturer funded 4 426 Risk Ratio (M-H, Fixed, 95% CI) 0.73 [0.54, 0.97]
1.2 Not manufacturer funded 2 141 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.47, 1.80]
1.3 Home made device 3 218 Risk Ratio (M-H, Fixed, 95% CI) 0.37 [0.17, 0.78]
Analysis 1.1. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 1
Surgical site infection.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 1 Surgical site infection
Study or subgroup NPWT Standard dressing Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Incisional wound
Crist 2014 5/49 2/42 25.7 % 2.14 [ 0.44, 10.48 ]
Howell 2011 1/24 1/36 9.5 % 1.50 [ 0.10, 22.84 ]
Masden 2012 3/44 5/37 64.8 % 0.50 [ 0.13, 1.97 ]
Subtotal (95% CI) 117 115 100.0 % 1.02 [ 0.41, 2.54 ]
Total events: 9 (NPWT), 8 (Standard dressing)
Heterogeneity: Chi2 = 1.94, df = 2 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
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Analysis 1.2. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 2
Surgical site infection using wound, not individual, as denominator.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 2 Surgical site infection using wound, not individual, as denominator
Study or subgroup NPWT Standard dressing Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stannard 2012 14/144 23/122 0.52 [ 0.28, 0.96 ]
0.05 0.2 1 5 20
Favours NPWT Favours standard dressing
Analysis 1.3. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 3
Dehiscence.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 3 Dehiscence
Study or subgroup NPWT Standard dressing Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Masden 2012 16/44 11/37 1.22 [ 0.65, 2.30 ]
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
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Analysis 1.4. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 4
Dehiscence using wounds, not individual, as denominator.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 4 Dehiscence using wounds, not individual, as denominator
Study or subgroup NPWT Standard dressing Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stannard 2012 12/139 20/122 0.48 [ 0.22, 1.03 ]
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
Analysis 1.5. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 5 Re-
operation.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 5 Re-operation
Study or subgroup NPWT Standard dressing Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Incisional wounds
Masden 2012 9/44 8/37 33.9 % 0.95 [ 0.41, 2.20 ]
Subtotal (95% CI) 44 37 33.9 % 0.95 [ 0.41, 2.20 ]
Total events: 9 (NPWT), 8 (Standard dressing)
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.90)
2 Skin grafts
Llanos 2006 5/30 12/30 46.8 % 0.42 [ 0.17, 1.04 ]
Petkar 2012 2/35 5/36 19.2 % 0.41 [ 0.09, 1.98 ]
Subtotal (95% CI) 65 66 66.1 % 0.42 [ 0.19, 0.92 ]
Total events: 7 (NPWT), 17 (Standard dressing)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.99); I2 =0.0%
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
(Continued . . . )
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(. . . Continued)
Study or subgroup NPWT Standard dressing Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 2.18 (P = 0.030)
Total (95% CI) 109 103 100.0 % 0.60 [ 0.34, 1.05 ]
Total events: 16 (NPWT), 25 (Standard dressing)
Heterogeneity: Chi2 = 1.95, df = 2 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.073)
Test for subgroup differences: Chi2 = 1.94, df = 1 (P = 0.16), I2 =48%
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
Analysis 1.6. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 6
Seroma/haematoma.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 6 Seroma/haematoma
Study or subgroup NPWT Standard dressing Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Wounds
Pachowsky 2011 4/9 9/10 0.49 [ 0.23, 1.05 ]
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
48Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.7. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 7 Graft
failure at 2 weeks.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 7 Graft failure at 2 weeks
Study or subgroup NPWT Standard dressing Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chio 2010 7/23 12/27 0.68 [ 0.32, 1.45 ]
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
Analysis 1.8. Comparison 1 Negative pressure wound therapy versus standard dressing, Outcome 8 Skin
blisters.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 1 Negative pressure wound therapy versus standard dressing
Outcome: 8 Skin blisters
Study or subgroup NPWT Standard dressing Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Howell 2011 15/24 3/36 7.50 [ 2.43, 23.14 ]
0.01 0.1 1 10 100
Favours NPWT Favours standard dressing
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Analysis 2.1. Comparison 2 Non-commercial NPWT versus commercial NPWT device, Outcome 1
Seroma/haematoma.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 2 Non-commercial NPWT versus commercial NPWT device
Outcome: 1 Seroma/haematoma
Study or subgroup
Non-
commercial
NPWT Commercial NPWT Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Wounds
Dorafshar 2011 0/45 1/42 0.31 [ 0.01, 7.44 ]
0.002 0.1 1 10 500
Favours non-commercial Favours commercial
Analysis 3.1. Comparison 3 Non-commercial NPWT versus standard care, Outcome 1 Re-operation.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 3 Non-commercial NPWT versus standard care
Outcome: 1 Re-operation
Study or subgroup Non-commercial Standard care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Llanos 2006 5/30 12/30 70.9 % 0.42 [ 0.17, 1.04 ]
Petkar 2012 2/35 5/36 29.1 % 0.41 [ 0.09, 1.98 ]
Total (95% CI) 65 66 100.0 % 0.42 [ 0.19, 0.92 ]
Total events: 7 (Non-commercial), 17 (Standard care)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.18 (P = 0.030)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours non-commercial Favours standard care
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Analysis 4.1. Comparison 4 Funded versus non-funded or unknown funding, Outcome 1 Any outcome.
Review: Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention
Comparison: 4 Funded versus non-funded or unknown funding
Outcome: 1 Any outcome
Study or subgroup NPWT Other Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Manufacturer funded
Howell 2011 1/24 1/36 0.9 % 1.50 [ 0.10, 22.84 ]
Masden 2012 28/44 24/37 27.7 % 0.98 [ 0.71, 1.36 ]
Pachowsky 2011 4/9 9/10 9.1 % 0.49 [ 0.23, 1.05 ]
Stannard 2012 14/144 23/122 26.5 % 0.52 [ 0.28, 0.96 ]
Subtotal (95% CI) 221 205 64.1 % 0.73 [ 0.54, 0.97 ]
Total events: 47 (NPWT), 57 (Other)
Heterogeneity: Chi2 = 5.70, df = 3 (P = 0.13); I2 =47%
Test for overall effect: Z = 2.16 (P = 0.031)
2 Not manufacturer funded
Chio 2010 7/23 12/27 11.7 % 0.68 [ 0.32, 1.45 ]
Crist 2014 5/49 2/42 2.3 % 2.14 [ 0.44, 10.48 ]
Subtotal (95% CI) 72 69 14.0 % 0.92 [ 0.47, 1.80 ]
Total events: 12 (NPWT), 14 (Other)
Heterogeneity: Chi2 = 1.69, df = 1 (P = 0.19); I2 =41%
Test for overall effect: Z = 0.24 (P = 0.81)
3 Home made device
Dorafshar 2011 0/45 3/42 3.8 % 0.13 [ 0.01, 2.51 ]
Llanos 2006 5/30 12/30 12.8 % 0.42 [ 0.17, 1.04 ]
Petkar 2012 2/35 5/36 5.2 % 0.41 [ 0.09, 1.98 ]
Subtotal (95% CI) 110 108 21.8 % 0.37 [ 0.17, 0.78 ]
Total events: 7 (NPWT), 20 (Other)
Heterogeneity: Chi2 = 0.55, df = 2 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 2.59 (P = 0.0097)
Total (95% CI) 403 382 100.0 % 0.68 [ 0.52, 0.87 ]
Total events: 66 (NPWT), 91 (Other)
Heterogeneity: Chi2 = 11.42, df = 8 (P = 0.18); I2 =30%
Test for overall effect: Z = 3.04 (P = 0.0024)
Test for subgroup differences: Chi2 = 3.51, df = 2 (P = 0.17), I2 =43%
0.01 0.1 1 10 100
Favours NPWT Favours other
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A P P E N D I C E S
Appendix 1. Search methods section from the original review
We searched the following electronic databases for the original version of this review
• the Cochrane Wounds Group Specialised Register (searched 11 November 2011);
• the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 4);
• Database of Abstracts of Reviews of Effects (The Cochrane Library 2011, Issue 4);
• Ovid MEDLINE (2005 to October Week 4 2011);
• Ovid MEDLINE (In-Process & Other Non-Indexed Citations 8 November 2011);
• Ovid EMBASE (2009 to 2011 Week 44);
• EBSCO CINAHL (1982 to 4 November 2011).
We used the following search strategy in the Cochrane Central Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor Negative-Pressure Wound Therapy explode all trees
#2 MeSH descriptor Suction explode all trees
#3 MeSH descriptor Vacuum explode all trees
#4 (“negative pressure” or negative-pressure or TNP):ti,ab,kw
#5 (sub-atmospheric or subatmospheric):ti,ab,kw
#6 ((seal* NEXT surface*) or (seal* NEXT aspirat*)):ti,ab,kw
#7 (wound NEAR/3 suction*):ti,ab,kw
#8¬(wound NEAR/3 drainage):ti,ab,kw
#9 ((foam NEXT suction) or (suction NEXT dressing*)):ti,ab,kw
#10 ((vacuum NEXT therapy) or (vacuum NEXT dressing*) or (vacuum NEXT seal*) or (vacuum NEXT assist*) or (vacuum NEAR
closure) or (vacuum NEXT compression) or (vacuum NEXT pack*) or (vacuum NEXT drainage) or VAC):ti,ab,kw
#11 (“vacuum assisted closure technique” or VAC):ti,ab,kw
#12 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11)
#13 MeSH descriptor Surgical Wound Infection explode all trees
#14 MeSH descriptor Surgical Wound Dehiscence explode all trees
#15 surg* NEAR/5 infect*:ti,ab,kw
#16 surg* NEAR/5 wound*:ti,ab,kw
#17 surg* NEAR/5 site*:ti,ab,kw
#18 surg* NEAR/5 incision*:ti,ab,kw
#19 surg* NEAR/5 dehisc*:ti,ab,kw
#20 wound* NEAR/5 dehisc*:ti,ab,kw
#21 (#13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20)
#22 (#12 AND #21)
The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL can be found in Appendix 2 ; Appendix 3 and
Appendix 4 respectively.¬We combined the OvidMEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying
randomised trials in MEDLINE: sensitivity- and precision-maximising version (2008 revision) (Lefebvre 2011). We combined the
EMBASE and CINAHL searches with the trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN 2011).
We conducted separate searches to identify economic evaluations in the following electronic databases:
• NHS Economic Evaluation Database (The Cochrane Library 2011, Issue 3);
• Ovid MEDLINE (1948 to July Week 3 2011);
• Ovid MEDLINE (In-Process & Other Non-Indexed Citations 28 July 2011);
• Ovid EMBASE (1980 to 2011 Week 29);
• EBSCO CINAHL (1982 to 20 July 2011)
We used economics filters developed by Centre for Reviews and Dissemination (CRD 2010) in combination with terms to describe the
condition and intervention in Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL searches (see Appendix 5; Appendix 6 and
Appendix 7 respectively). We did not restrict any of the above searches with respect to language, date of publication or study setting.
We searched the following clinical trials registries for details of relevant protocols and contacted the relevant research team:
• Clinical trials.gov;
• World Health Organization (WHO) International Clinical Trials Registry Platform;
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• Australian and New Zealand Clinical Trials Registry;
• Current Controlled Trials.
Appendix 2. Ovid MEDLINE effectiveness search strategy
1 exp Negative-Pressure Wound Therapy/
2 exp Suction/
3 exp Vacuum/
4 (negative pressure or negative-pressure or TNP).tw.
5 (sub-atmospheric or subatmospheric).tw.
6 ((seal* adj surface*) or (seal* adj aspirat*)).tw.
7 (wound adj2 suction*).tw.
8 (wound adj5 drainage).tw.
9 ((foam adj suction) or (suction adj dressing*)).tw.
10 (vacuum assisted closure technique or VAC).tw.
11 ((vacuum adj therapy) or (vacuum adj dressing*) or (vacuum adj seal*) or (vacuum adj closure) or (vacuum adj compression) or
(vacuum adj pack*) or (vacuum adj drainage) or (suction* adj drainage)).tw.
12 or/1-11
13 exp Surgical Wound Infection/
14 exp Surgical Wound Dehiscence/
15 (surg* adj5 infect*).tw.
16 (surg* adj5 wound*).tw.
17 (surg* adj5 site*).tw.
18 (surg* adj5 incision*).tw.
19 (surg* adj5 dehisc*).tw.
20 (wound* adj5 dehisc*).tw.
21 (wound* adj5 dehisc*).tw.
22 or/13-21
23 12 and 22
24 randomized controlled trial.pt.
25 controlled clinical trial.pt.
26 randomized.ab.
27 placebo.ab.
28 clinical trials as topic.sh.
29 randomly.ab.
30 trial.ti.
31 or/24-30
32 (animals not (humans and animals)).sh.
33 31 not 32
34 23 and 33
35 (2005* or 2006* or 2007* or 2008* or 2009* or 2010*).ed.
36 34 and 35
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Appendix 3. Ovid EMBASE effectiveness search strategy
1 exp suction drainage/
2 exp vacuum assisted closure/
3 (negative pressure or negative-pressure or TNP).tw.
4 (sub-atmospheric or subatmospheric).tw.
5 ((seal* adj surface*) or (seal* adj aspirat*)).tw.
6 (wound adj2 suction*).tw.
7 (wound adj5 drainage).tw.
8 ((foam adj suction) or (suction adj dressing*)).tw.
9 (vacuum assisted closure technique or VAC).tw.
10 ((vacuum adj therapy) or (vacuum adj dressing*) or (vacuum adj seal*) or (vacuum adj closure) or (vacuum adj compression) or
(vacuum adj pack*) or (vacuum adj drainage) or (suction* adj drainage)).tw.
11 or/1-10
12 exp Surgical Wound Infection/
13 exp Surgical Wound Dehiscence/
14 (surg* adj5 infection*).tw.
15 (surg* adj5 wound*).tw.
16 (surg* adj5 site*).tw.
17 (surg* adj5 incision*).tw.
18 (surg* adj5 dehisc*).tw.
19 (wound* adj5 dehisc*).tw.
20 or/12-19
21 11 and 20
22 Clinical trial/
23 Randomized controlled trials/
24 Random Allocation/
25 Single-Blind Method/
26 Double-Blind Method/
27 Cross-Over Studies/
28 Placebos/
29 Randomi?ed controlled trial$.tw.
30 RCT.tw.
31 Random allocation.tw.
32 Randomly allocated.tw.
33 Allocated randomly.tw.
34 (allocated adj2 random).tw.
35 Single blind$.tw.
36 Double blind$.tw.
37 ((treble or triple) adj blind$).tw.
38 Placebo$.tw.
39 Prospective Studies/
40 or/22-39
41 Case study/
42 Case report.tw.
43 Abstract report/ or letter/
44 or/41-43
45 40 not 44
46 animal/
47 human/
48 46 not 47
49 45 not 48
50 21 and 49
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51 (2009* or 2010* or 2011*).em.
52 50 and 51
Appendix 4. EBSCO CINAHL effectiveness search strategy
S22 S12 and S21
S21 S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20
S20 TI wound* N5 dehisc* or AB wound* N5 dehisc*
S19 TI surg* N5 dehisc* or AB surg* N5 dehisc*
S18 TI surg* N5 incision* or AB surg* N5 incision*
S17 TI surg* N5 site* or AB surg* N5 site*
S16 TI surg* N5 wound* or AB surg* N5 wound*
S15 TI surg* N5 infection* or AB surg* N5 infection*
S14 (MH “Surgical Wound Dehiscence”)
S13 (MH “Surgical Wound Infection”)
S12 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11
S11 TI ( foam suction or suction dressing* or suction drainage ) or AB ( foam suction or suction dressing* or suction drainage )
S10 AB vacuum therapy or vacuum dressing* or vacuum seal* or vacuum closure or vacuum compression or vacuum pack or vacuum
drainage
S9 TI vacuum therapy or vacuum dressing* or vacuum seal* or vacuum closure or vacuum compression or vacuum pack or vacuum
drainage
S8 TI wound N5 drainage or AB wound N5 drainage
S7 TI wound N5 suction* or AB wound N5 suction*
S6 TI ( seal* N1 surface* or seal* N1 aspirat* ) or AB ( seal* N1 surface* or seal* N1 aspirat* )
S5 TI ( sub-atmospheric or subatmospheric ) or AB ( sub-atmospheric or subatmospheric )
S4 TI ( negative pressure or negative-pressure or TNP ) or AB ( negative pressure or negative-pressure or TNP )
S3 (MH “Negative Pressure Wound Therapy”)
S2 (MH “Vacuum”)
S1 (MH “Suction+”)
Appendix 5. Ovid MEDLINE economics search strategy
1 exp Negative-Pressure Wound Therapy/
2 exp Suction/
3 exp Vacuum/
4 (negative pressure or negative-pressure or TNP).tw.
5 (sub-atmospheric or subatmospheric).tw.
6 ((seal* adj surface*) or (seal* adj aspirat*)).tw.
7 (wound adj2 suction*).tw.
8 (wound adj5 drainage).tw.
9 ((foam adj suction) or (suction adj dressing*)).tw.
10 (vacuum assisted closure technique or VAC).tw.
11 ((vacuum adj therapy) or (vacuum adj dressing*) or (vacuum adj seal*) or (vacuum adj closure) or (vacuum adj compression) or
(vacuum adj pack*) or (vacuum adj drainage) or (suction* adj drainage)).tw.
12 or/1-11
13 exp Surgical Wound Infection/
14 exp Surgical Wound Dehiscence/
15 (surg* adj5 infect*).tw.
16 (surg* adj5 wound*).tw.
17 (surg* adj5 site*).tw.
18 (surg* adj5 incision*).tw.
19 (surg* adj5 dehisc*).tw.
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20 (wound* adj5 dehisc*).tw.
21 (wound* adj5 dehisc*).tw.
22 or/13-21
23 12 and 22
24 economics/
25 exp “costs and cost analysis”/
26 economics, dental/
27 exp “economics, hospital”/
28 economics, medical/
29 economics, nursing/
30 economics, pharmaceutical/
31 (economic* or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic*).ti,ab.
32 (expenditure* not energy).ti,ab.
33 value for money.ti,ab.
34 budget*.ti,ab.
35 or/24-34
36 ((energy or oxygen) adj cost).ti,ab.
37 (metabolic adj cost).ti,ab.
38 ((energy or oxygen) adj expenditure).ti,ab.
39 or/36-38
40 35 not 39
41 letter.pt.
42 editorial.pt.
43 historical article.pt.
44 or/41-43
45 40 not 44
46 Animals/
47 Humans/
48 46 not (46 and 47)
49 45 not 48
50 23 and 49
Appendix 6. Ovid EMBASE economics search strategy
1 exp suction drainage/
2 exp vacuum assisted closure/
3 (negative pressure or negative-pressure or TNP).tw.
4 (sub-atmospheric or subatmospheric).tw.
5 ((seal* adj surface*) or (seal* adj aspirat*)).tw.
6 (wound adj2 suction*).tw.
7 (wound adj5 drainage).tw.
8 ((foam adj suction) or (suction adj dressing*)).tw.
9 (vacuum assisted closure technique or VAC).tw.
10 ((vacuum adj therapy) or (vacuum adj dressing*) or (vacuum adj seal*) or (vacuum adj closure) or (vacuum adj compression) or
(vacuum adj pack*) or (vacuum adj drainage) or (suction* adj drainage)).tw.
11 or/1-10
12 exp Surgical Wound Infection/
13 exp Surgical Wound Dehiscence/
14 (surg* adj5 infection*).tw.
15 (surg* adj5 wound*).tw.
16 (surg* adj5 site*).tw.
17 (surg* adj5 incision*).tw.
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18 (surg* adj5 dehisc*).tw.
19 (wound* adj5 dehisc*).tw.
20 or/12-19
21 11 and 20
22 health-economics/
23 exp economic-evaluation/
24 exp health-care-cost/
25 exp pharmacoeconomics/
26 or/22-25
27 (econom* or cost or costs or costly or costing or price or prices or pricing or pharmacoeconomic*).ti,ab.
28 (expenditure* not energy).ti,ab.
29 (value adj2 money).ti,ab.
30 budget*.ti,ab.
31 or/27-30
32 26 or 31
33 letter.pt.
34 editorial.pt.
35 note.pt.
36 or/33-35
37 32 not 36
38 (metabolic adj cost).ti,ab.
39 ((energy or oxygen) adj cost).ti,ab.
40 ((energy or oxygen) adj expenditure).ti,ab.
41 or/38-40
42 37 not 41
43 exp animal/
44 exp animal-experiment/
45 nonhuman/
46 (rat or rats or mouse or mice or hamster or hamsters or animal or animals or dog or dogs or cat or cats or bovine or sheep).ti,ab,sh.
47 or/43-46
48 exp human/
49 exp human-experiment/
50 or/48-49
51 47 not (47 and 50)
52 42 not 51
53 21 and 52
Appendix 7. EBSCO CINAHL economics search strategy
S45 S22 and S44
S44 S40 NOT S43
S43 S19 NOT (S19 AND S42)
S42 MH “Human”
S41 MH “Animal Studies”
S40 S35 NOT S39
S39 S36 or S37 or S38
S38 PT commentary
S37 PT letter
S36 PT editorial
S35 S33 OR S34
S34 TI (cost or costs or economic* or pharmacoeconomic* or price* or pricing*) OR AB (cost or costs or economic* or pharmacoeco-
nomic* or price* or pricing*)
57Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S33 S29 OR S32
S32 S30 OR S31
S31 MH “Health Resource Utilization”
S30 MH “Health Resource Allocation”
S29 S23 NOT S28
S28 S24 or S25 or S26 or S27
S27 MH “Business+”
S26 MH “Financing, Organized+”
S25 MH “Financial Support+”
S24 MH “Financial Management+”
S23 MH “Economics+”
S22 S12 and S21
S21 S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20
S20 TI wound* N5 dehisc* or AB wound* N5 dehisc*
S19 TI surg* N5 dehisc* or AB surg* N5 dehisc*
S18 TI surg* N5 incision* or AB surg* N5 incision*
S17 TI surg* N5 site* or AB surg* N5 site*
S16 TI surg* N5 wound* or AB surg* N5 wound*
S15 TI surg* N5 infection* or AB surg* N5 infection*
S14 (MH “Surgical Wound Dehiscence”)
S13 (MH “Surgical Wound Infection”)
S12 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11
S11 TI foam suction or suction dressing* or suction drainage or AB foam suction or suction dressing* or suction drainage
S10 AB vacuum therapy or vacuum dressing* or vacuum seal* or vacuum closure or vacuum compression or vacuum pack or vacuum
drainage
S9 TI vacuum therapy or vacuum dressing* or vacuum seal* or vacuum closure or vacuum compression or vacuum pack or vacuum
drainage
S8 TI wound N5 drainage or AB wound N5 drainage
S7 TI wound N5 suction* or AB wound N5 suction*
S6 TI seal* N1 surface* or seal* N1 aspirat* or AB seal* N1 surface* or seal* N1 aspirat*
S5 TI sub-atmospheric or subatmospheric or AB sub-atmospheric or subatmospheric
S4 TI negative pressure or negative-pressure or TNP or AB negative pressure or negative-pressure or TNP
S3 (MH “Negative Pressure Wound Therapy”)
S2 (MH “Vacuum”)
S1 (MH “Suction+”)
Appendix 8. Risk of bias criteria
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
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Unclear
Insufficient information about the sequence generation process provided to permit judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: using an open random allocation schedule (e.g. a list of randomnumbers); assignment envelopes were usedwithout appropriate
safeguards (e.g. if envelopes were unsealed or nonopaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not
described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described,
but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others was unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others was likely to introduce bias.
Unclear
Either of the following.
• Insufficient information provided to permit judgement of low or high risk of bias.
• The study did not address this outcome.
59Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk is not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes was not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk is enough to induce
clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes is enough to induce clinically relevant bias in observed effect size.
• ‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Any one of the following.
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following.
• The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the
review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon)
High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that
were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect).
60Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information provided to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into
this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• had extreme baseline imbalance; or
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
Appendix 9. Glossary of terms
Term Description
Dehiscence Wound dehiscence is a complication of surgery in which a wound breaks open along
the line of the surgical incision
GSUC GSUC is a system of negative pressure wound therapy. It is based on a gauze dressing
moistened with 0.9% normal saline into which a red rubber catheter is inserted. The
dressing is then sealed with an occlusive cover and continuous wall suction at -75
mmHg to -80 mmHg applied
Negative pressure wound therapy (NPWT) NPWT is based on a closed sealed system that produces negative pressure to the wound
surface. The wound is covered or packed with an open-cell foam or gauze dressing
and sealed with an occlusive drape. Intermittent or continuous suction is maintained
by connecting suction tubes from the wound dressing to a vacuum pump and liquid
waste collector. Standard negative pressure rates range between -50 mmHg and -125
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(Continued)
mm Hg (Ubbink 2008; Vikatmaa 2008)
Risk ratio (RR) The risk ratio or relative risk (RR) is the probability that a member of a group who
is exposed to an intervention will develop an event relative to the probability that a
member of an unexposed group will develop that same event
WH A T ’ S N E W
Last assessed as up-to-date: 28 January 2014.
Date Event Description
24 February 2015 Amended Contact details updated.
H I S T O R Y
Protocol first published: Issue 8, 2011
Review first published: Issue 4, 2012
Date Event Description
27 August 2014 New search has been performed First update, new search.
27 August 2014 New citation required but conclusions have not
changed
Four trials added (Crist 2014; Masden 2012; Petkar
2012; Stannard 2012), no change to conclusions
13 November 2013 Amended Acknowledgement added to the funders
16 May 2012 Amended adjustments to text
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External sources
• The National Institute for Health research (NIHR) is the sole funder of the Cochrane Wounds Group, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added one intervention: comparisons between different negative pressure devices.
The list of abstracted data was expanded to include:
• study dates;
• number of participants per group;
• information about ethics approval, consent and conflict of interest.
In trials of skin grafts, graft failure is an important outcome. We failed to include this as either a primary or secondary outcome in
the original review but believe, for this and for future updates that failure of skin grafts should be included. We also failed to include
length of hospital stay, which is important for any economic analysis. Consequently, graft failure and length of hospital stay have been
included as additional outcomes post hoc.
• In this update, we removed one primary outcome “Proportion of surgical wounds healing by primary intention that completely
heal (surgical wounds may include split skin grafts, full skin grafts or any primary wound closure)”. The decision was based on our
experience conducting the first version of this review where we noted that “ . . . it has become clear to us that this outcome is not
appropriate for surgery that is expected to heal by primary intention; most clean surgical wounds will completely heal in a relatively
short time. Moreover, determining when a surgical incision is ’completely healed’ is difficult. Consequently, wound healing should
not be included as a primary outcome for future updates”.
• In the first version of the review, any wound complications were considered under the heading ’Adverse events’. As many of these
’events’ are qualitatively different and of varying levels of importance, we have now included only ’Surgical site infection’ and
’Dehiscence’ under the heading ’Adverse events’. Other wound-related outcomes that were previously included under the ’Adverse
events’ primary outcome (such as fracture blisters, seromas etc) have been moved to ’Secondary outcomes’. We have also added two
new secondary outcomes; re-operation and graft loss. The first was added as important outcome that indicates the severity of any
wound dehiscence or graft loss. Graft loss has been added because it is an important outcome for skin graft studies and previously we
did not include any outcomes that were specific to skin grafts.
• We have changed wording in the section ’Unit of analysis issues’ (we had not anticipated that multiple wounds might be an issue
in the original version of the review) and ’Dealing with missing data’ (to clarify what we intend to do).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Skin Transplantation; ∗Wound Healing; Bandages; Negative-Pressure Wound Therapy [instrumentation; ∗methods]; Orthopedic
Procedures; Randomized Controlled Trials as Topic; Surgical Procedures, Operative; Surgical Wound Dehiscence [prevention &
control]; Wounds and Injuries [surgery]
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MeSH check words
Humans
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